|
NZ501276A
(en)
|
1997-07-01 |
2000-10-27 |
Warner Lambert Co |
4-bromo or 4-iodo phenylamino benzhydroxamic acid derivatives and their use as MEK inhibitors in treating proliferative disorders
|
|
US5932580A
(en)
|
1997-12-01 |
1999-08-03 |
Yissum Research And Development Company Of The Hebrew University Of Jerusalem |
PDGF receptor kinase inhibitory compounds their preparation and compositions
|
|
ATE269295T1
(de)
|
1998-04-17 |
2004-07-15 |
Parker Hughes Inst |
Btk inhibitoren und verfahren zur identifizierung und verwendung
|
|
HUP0102563A3
(en)
|
1998-05-04 |
2003-04-28 |
Zentaris Gmbh |
Indole derivatives and their use in the treatment of malignant and other diseases caused by pathological cell proliferation
|
|
ATE311363T1
(de)
|
1999-01-13 |
2005-12-15 |
Warner Lambert Co |
Sulfohydroxamsäure and sulfohydroxamate und ihre verwendung als mek-inhibitoren
|
|
CA2348236A1
(en)
|
1999-01-13 |
2000-07-20 |
Stephen Douglas Barrett |
4-arylamino, 4-aryloxy, and 4-arylthio diarylamines and derivatives thereof as selective mek inhibitors
|
|
CA2349832A1
(en)
|
1999-01-13 |
2000-07-20 |
Warner-Lambert Company |
Benzenesulfonamide derivatives and their use as mek inhibitors
|
|
IL144214A0
(en)
|
1999-01-13 |
2002-05-23 |
Warner Lambert Co |
Benzoheterocycles and their use as mek inhibitors
|
|
AU3761400A
(en)
|
1999-03-19 |
2000-10-09 |
Du Pont Pharmaceuticals Company |
Amino-thio-acrylonitriles as mek inhibitors
|
|
GB9910577D0
(en)
|
1999-05-08 |
1999-07-07 |
Zeneca Ltd |
Chemical compounds
|
|
ATE288420T1
(de)
|
1999-06-09 |
2005-02-15 |
Yamanouchi Pharma Co Ltd |
Neuartige heterocyclische carboxamid-derivate
|
|
GB9918035D0
(en)
|
1999-07-30 |
1999-09-29 |
Novartis Ag |
Organic compounds
|
|
CA2384378C
(en)
|
1999-10-06 |
2011-05-24 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Heterocyclic compounds useful as inhibitors of tyrosine kinases
|
|
UA74803C2
(uk)
|
1999-11-11 |
2006-02-15 |
Осі Фармасьютікалз, Інк. |
Стійкий поліморф гідрохлориду n-(3-етинілфеніл)-6,7-біс(2-метоксіетокси)-4-хіназолінаміну, спосіб його одержання (варіанти) та фармацевтичне застосування
|
|
WO2001047922A2
(en)
|
1999-12-24 |
2001-07-05 |
Aventis Pharma Limited |
Azaindoles
|
|
EP1250137B1
(en)
|
2000-01-24 |
2007-08-15 |
Genzyme Corporation |
Jak/stat pathway inhibitors and the use thereof for the treatment of primary generalized osteoarthritis
|
|
JP3663382B2
(ja)
|
2000-02-15 |
2005-06-22 |
スージェン・インコーポレーテッド |
ピロール置換２−インドリノン蛋白質キナーゼ阻害剤
|
|
US7087608B2
(en)
|
2000-03-03 |
2006-08-08 |
Robert Charles Atkins |
Use of PDGF receptor tyrosine kinase inhibitors for the treatment of diabetic nephropathy
|
|
MXPA02008103A
(es)
|
2000-03-15 |
2002-11-29 |
Warner Lambert Co |
Diarilaminas sustituidas con 5-amida como inhibidores mek.
|
|
AR028261A1
(es)
|
2000-03-28 |
2003-04-30 |
Wyeth Corp |
Inhibidores triciclicos de la proteina quinasa
|
|
AR035851A1
(es)
|
2000-03-28 |
2004-07-21 |
Wyeth Corp |
3-cianoquinolinas, 3-ciano-1,6-naftiridinas y 3-ciano-1,7-naftiridinas como inhibidoras de proteina quinasas
|
|
DE10017480A1
(de)
|
2000-04-07 |
2001-10-11 |
Transmit Technologietransfer |
Verwendung von Substanzen, die als MEK Inhibitor wirken, zur Herstellung eines Arneimittels gegen DNA- und RNA-Viren
|
|
JP2001302667A
(ja)
|
2000-04-28 |
2001-10-31 |
Bayer Ag |
イミダゾピリミジン誘導体およびトリアゾロピリミジン誘導体
|
|
EP1420778B1
(en)
|
2001-03-06 |
2006-11-22 |
Dorian Bevec |
Use of mek inhibitors for treating virus induced hemorrhagic shock or fever
|
|
ATE427948T1
(de)
|
2001-04-24 |
2009-04-15 |
Purdue Research Foundation |
Folat-mimetika und deren folatrezeptorbindende konjugate
|
|
TWI238824B
(en)
|
2001-05-14 |
2005-09-01 |
Novartis Ag |
4-amino-5-phenyl-7-cyclobutyl-pyrrolo[2,3-d]pyrimidine derivatives
|
|
EP1401429A2
(en)
|
2001-06-29 |
2004-03-31 |
AB Science |
Use of potent, selective and non toxic c-kit inhibitors for treating mastocytosis
|
|
US20040266797A1
(en)
|
2001-06-29 |
2004-12-30 |
Alain Moussy |
Use of potent,selective and non toxic c-kit inhibitors for treating tumor angiogensis
|
|
WO2003003006A2
(en)
|
2001-06-29 |
2003-01-09 |
Ab Science |
New potent, selective and non toxic c-kit inhibitors
|
|
ATE388711T1
(de)
|
2001-09-20 |
2008-03-15 |
Ab Science |
C-kithemmer zur behandlung von bakteriellen infektionen
|
|
EP1430053B1
(en)
|
2001-09-27 |
2006-10-25 |
SmithKline Beecham Corporation |
AZAOXOINDOLE DERIVATIVES AS Trk PROTEIN KINASE INHIBITORS FOR THE TREATMENT OF CANCER AND CHRONIC PAIN
|
|
US20030158195A1
(en)
|
2001-12-21 |
2003-08-21 |
Cywin Charles L. |
1,6 naphthyridines useful as inhibitors of SYK kinase
|
|
TWI329105B
(en)
|
2002-02-01 |
2010-08-21 |
Rigel Pharmaceuticals Inc |
2,4-pyrimidinediamine compounds and their uses
|
|
US7235537B2
(en)
|
2002-03-13 |
2007-06-26 |
Array Biopharma, Inc. |
N3 alkylated benzimidazole derivatives as MEK inhibitors
|
|
EP1482944A4
(en)
|
2002-03-13 |
2006-04-19 |
Array Biopharma Inc |
NZ ALKYL BENZIMIDAZOLE DERIVATIVES AS MEK INHIBITORS
|
|
KR100984595B1
(ko)
|
2002-03-13 |
2010-09-30 |
어레이 바이오파마 인크. |
Ｍｅｋ 억제제로서의 ｎ3 알킬화 벤즈이미다졸 유도체
|
|
US20050124624A1
(en)
|
2002-03-15 |
2005-06-09 |
Gilbert Richard E. |
4-(4-methylpiperazin-1-ylmethyl)-n-[4-methyl-3-(4-pyridin-3-yl)pyrimidin-2-yl-amino)phenyl]-benzamide for threating ang ii-mediated diseases
|
|
RU2004135386A
(ru)
|
2002-05-06 |
2005-07-20 |
Вертекс Фармасьютикалз Инкорпорейтед (Us) |
Тиадиазолы или оксадиазолы и их применение в качестве ингибиторов протеинкиназы jak
|
|
JP2005528443A
(ja)
|
2002-05-30 |
2005-09-22 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
Ｊａｋキナーゼおよびｃｄｋ２プロテインキナーゼのインヒビター
|
|
GB0215823D0
(en)
|
2002-07-09 |
2002-08-14 |
Astrazeneca Ab |
Quinazoline derivatives
|
|
EP1527071A1
(en)
|
2002-07-25 |
2005-05-04 |
Pfizer Products Inc. |
Isothiazole derivatives useful as anticancer agents
|
|
MXPA05001277A
(es)
|
2002-08-02 |
2005-10-06 |
Ab Science |
2-(3-aminoaril)amino-4-aril-tiazoles y su uso como inhibidores del c-kit.
|
|
AU2003286876A1
(en)
|
2002-11-01 |
2004-06-07 |
Vertex Pharmaceuticals Incorporated |
Compositions useful as inhibitors of jak and other protein kinases
|
|
US7259161B2
(en)
|
2002-11-04 |
2007-08-21 |
Vertex Pharmaceuticals Incorporated |
Compositions useful as inhibitors of JAK and other protein kinases
|
|
EP1560824A1
(en)
|
2002-11-05 |
2005-08-10 |
Vertex Pharmaceuticals Incorporated |
Compounds useful as inhibitors of jak and other protein kinases
|
|
US7098332B2
(en)
|
2002-12-20 |
2006-08-29 |
Hoffmann-La Roche Inc. |
5,8-Dihydro-6H-pyrido[2,3-d]pyrimidin-7-ones
|
|
ATE508747T1
(de)
|
2003-03-10 |
2011-05-15 |
Eisai R&D Man Co Ltd |
C-kit kinase-hemmer
|
|
GB0305929D0
(en)
|
2003-03-14 |
2003-04-23 |
Novartis Ag |
Organic compounds
|
|
EP1648455A4
(en)
|
2003-07-23 |
2009-03-04 |
Exelixis Inc |
MODULATORS OF ALK PROTEIN (ANAPLASTIC LYMPHOMA KINASE) AND METHODS OF USE
|
|
WO2005018677A2
(en)
|
2003-08-01 |
2005-03-03 |
Wyeth Holdings Corporation |
Use of combination of an epidermal growth factor receptor kinase inhibitor and cytotoxic agents for treatment and inhibition of cancer
|
|
PT1660458E
(pt)
|
2003-08-15 |
2012-04-27 |
Novartis Ag |
2,4-pirimidinodiaminas úteis no tratamento de doenças neoplásicas, desordens inflamatórias e do sistema imunitário
|
|
AU2004268948A1
(en)
|
2003-08-21 |
2005-03-10 |
Osi Pharmaceuticals, Inc. |
N-substituted pyrazolyl-amidyl-benzimidazolyl c-kit inhibitors
|
|
JP4769720B2
(ja)
|
2003-08-21 |
2011-09-07 |
オーエスアイ・ファーマシューテイカルズ・エル・エル・シー |
Ｎ−置換ベンズイミダゾリルｃ−Ｋｉｔ阻害剤
|
|
MXPA06002019A
(es)
|
2003-08-21 |
2006-05-31 |
Osi Pharm Inc |
Imidazopiridinas n3 sustituidas inhibidoras de c_kit.
|
|
US7144907B2
(en)
|
2003-09-03 |
2006-12-05 |
Array Biopharma Inc. |
Heterocyclic inhibitors of MEK and methods of use thereof
|
|
US7538120B2
(en)
|
2003-09-03 |
2009-05-26 |
Array Biopharma Inc. |
Method of treating inflammatory diseases
|
|
DE10342794A1
(de)
|
2003-09-16 |
2005-04-21 |
Basf Ag |
Sekretion von Proteinen aus Hefen
|
|
GB0321710D0
(en)
|
2003-09-16 |
2003-10-15 |
Novartis Ag |
Organic compounds
|
|
TW200520745A
(en)
|
2003-09-19 |
2005-07-01 |
Chugai Pharmaceutical Co Ltd |
Novel 4-phenylamino-benzaldoxime derivatives and uses thereof as mitogen-activated protein kinase kinase (MEK) inhibitors
|
|
US20080085902A1
(en)
|
2003-09-23 |
2008-04-10 |
Guido Bold |
Combination Of A Vegf Receptor Inhibitor Or With A Chemotherapeutic Agent
|
|
UA83509C2
(en)
|
2003-10-15 |
2008-07-25 |
Оси Фармасьютикалз, Инк. |
Imidazopyrazines as tyrosine kinase inhibitors
|
|
US7476729B2
(en)
|
2003-10-24 |
2009-01-13 |
Institut Curie |
Dbait and uses thereof
|
|
EP1526177A1
(en)
|
2003-10-24 |
2005-04-27 |
Institut Curie |
Nucleic acids useful for triggering tumor cell lethality
|
|
MY141220A
(en)
|
2003-11-17 |
2010-03-31 |
Astrazeneca Ab |
Pyrazole derivatives as inhibitors of receptor tyrosine kinases
|
|
CN1905873A
(zh)
|
2003-11-19 |
2007-01-31 |
阵列生物制药公司 |
Mek的杂环抑制剂及其使用方法
|
|
DE102004001607A1
(de)
|
2004-01-09 |
2005-08-11 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue Arzneimittelkombinationen auf der Basis von Scopin- oder Tropensäureestern mit EGFR-Kinase-Hemmern
|
|
CA2554925A1
(en)
|
2004-01-30 |
2005-08-11 |
Ab Science |
2-(3-substituted-aryl)amino-4-aryl-thiazoles as tyrosine kinase inhibitors
|
|
US7531532B2
(en)
|
2004-02-27 |
2009-05-12 |
Eisai R&D Management Co., Ltd. |
Pyridine derivative and pyrimidine derivative
|
|
ES2364340T3
(es)
|
2004-03-30 |
2011-08-31 |
Vertex Pharmaceuticals Incorporated |
Azaindoles útiles como inhibidores de jak y otras proteína quinasas.
|
|
FR2868422B1
(fr)
|
2004-03-31 |
2006-07-14 |
Aventis Pharma Sa |
Nouveaux derives pyrrolo(2,3-b) pyridine, leur preparation et leur utilisation pharmaceutique comme inhibiteurs de kinases
|
|
EP2168968B1
(en)
|
2004-04-02 |
2017-08-23 |
OSI Pharmaceuticals, LLC |
6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitors
|
|
MXPA06014696A
(es)
|
2004-06-15 |
2007-02-12 |
Astrazeneca Ab |
Quinazolonas sustituidas como agentes anticancerosos.
|
|
TW200616974A
(en)
|
2004-07-01 |
2006-06-01 |
Astrazeneca Ab |
Chemical compounds
|
|
CN103251953A
(zh)
|
2004-07-19 |
2013-08-21 |
约翰·霍普金斯大学 |
供免疫抑制的flt3抑制剂
|
|
TWI361066B
(en)
|
2004-07-26 |
2012-04-01 |
Chugai Pharmaceutical Co Ltd |
5-substituted-2-phenylamino benzamides as mek inhibitors
|
|
WO2007040469A2
(en)
|
2005-09-15 |
2007-04-12 |
Kosak Ken M |
Chloroquine coupled compositions and methods for their synthesis
|
|
CA2577275A1
(en)
|
2004-08-31 |
2006-03-09 |
Astrazeneca Ab |
Quinazolinone derivatives and their use as b-raf inhibitors
|
|
MX2007002433A
(es)
|
2004-09-01 |
2007-05-04 |
Astrazeneca Ab |
Derivados de quinazolinona y su uso como inhibidores de b-raf.
|
|
CN101039933B
(zh)
|
2004-09-17 |
2012-06-06 |
沃泰克斯药物股份有限公司 |
可用作蛋白激酶抑制剂的二氨基三唑化合物
|
|
MX2007004480A
(es)
|
2004-10-15 |
2007-05-08 |
Astrazeneca Ab |
Quinoxalinas como inhibidores b raf.
|
|
EP1838675A1
(en)
|
2004-11-24 |
2007-10-03 |
Laboratoires Serono S.A. |
Novel 4-arylamino pyridone derivatives as mek inhibitors for the treatment of hyperproliferative disorders
|
|
AU2005309019A1
(en)
|
2004-11-24 |
2006-06-01 |
Novartis Ag |
Combinations of JAK inhibitors and at least one of Bcr-Abl, Flt-3, FAK or RAF kinase inhibitors
|
|
EP1828184B1
(en)
|
2004-12-01 |
2009-09-16 |
Merck Serono SA |
[1,2,4]triazolo[4,3-a]pyridine derivatives for the treatment of hyperproliferative diseases
|
|
CA2589770A1
(en)
|
2004-12-01 |
2006-06-08 |
Osi Pharmaceuticals, Inc. |
N-substituted benzimidazolyl c-kit inhibitors and combinatorial benzimidazole library
|
|
AR054416A1
(es)
|
2004-12-22 |
2007-06-27 |
Incyte Corp |
Pirrolo [2,3-b]piridin-4-il-aminas y pirrolo [2,3-b]pirimidin-4-il-aminas como inhibidores de las quinasas janus. composiciones farmaceuticas.
|
|
CN101128454A
(zh)
|
2004-12-22 |
2008-02-20 |
阿斯利康(瑞典)有限公司 |
用作抗癌药物的吡啶羧酰胺衍生物
|
|
CN101146789A
(zh)
|
2005-01-25 |
2008-03-19 |
阿斯利康(瑞典)有限公司 |
化合物
|
|
ES2426482T3
(es)
|
2005-01-27 |
2013-10-23 |
Kyowa Hakko Kirin Co., Ltd. |
Inhibidor de IGF-1R
|
|
BRPI0606793A8
(pt)
|
2005-02-04 |
2018-03-13 |
Astrazeneca Ab |
composto ou um sal farmaceuticamente aceitável do mesmo, processo para a preparação e uso do mesmo, métodos para a inibição da atividade de trk, para o tratamento ou profilaxia de câncer e para a produção de um efeito anti-proliferativo em um animal de sangue quente, e, composição farmacêutica
|
|
SI1853588T1
(sl)
|
2005-02-16 |
2008-10-31 |
Astrazeneca Ab |
Kemične spojine
|
|
ES2347172T3
(es)
|
2005-02-16 |
2010-10-26 |
Astrazeneca Ab |
Compuestos quimicos.
|
|
BRPI0607062A2
(pt)
|
2005-02-28 |
2009-08-04 |
Japan Tobacco Inc |
composto de aminopiridina com atividade inibidora de syk, composição farmacêutica e agente terapêutico compreendendo os mesmos
|
|
AU2006229343A1
(en)
|
2005-03-28 |
2006-10-05 |
Kirin Pharma Kabushiki Kaisha |
Thienopyridine derivative, or quinoline derivative, or quinazoline derivative, having c-Met autophosphorylation inhibiting potency
|
|
WO2006106437A2
(en)
|
2005-04-04 |
2006-10-12 |
Ab Science |
Substituted oxazole derivatives and their use as tyrosine kinase inhibitors
|
|
KR20080011199A
(ko)
|
2005-04-19 |
2008-01-31 |
교와 핫꼬 고교 가부시끼가이샤 |
질소 함유 복소환 화합물
|
|
US20080287437A1
(en)
|
2005-05-16 |
2008-11-20 |
Astrazeneca Ab |
Pyrazolylaminopyrimidine Derivatives Useful as Tyrosine Kinase Inhibitors
|
|
ES2405785T3
(es)
|
2005-05-18 |
2013-06-03 |
Array Biopharma Inc. |
Inhibidores heterocíclicos de MEK y métodos de uso de los mismos
|
|
WO2006130673A1
(en)
|
2005-05-31 |
2006-12-07 |
Janssen Pharmaceutica, N.V. |
3-benzoimidazolyl-pyrazolopyridines useful in treating kinase disorders
|
|
WO2006133417A1
(en)
|
2005-06-07 |
2006-12-14 |
Valeant Pharmaceuticals International |
Phenylamino isothiazole carboxamidines as mek inhibitors
|
|
US20070021435A1
(en)
|
2005-06-10 |
2007-01-25 |
Gaul Michael D |
Aminopyrimidines as kinase modulators
|
|
WO2007002254A2
(en)
|
2005-06-23 |
2007-01-04 |
Merck & Co., Inc. |
Benzocycloheptapyridines as inhibitors of the receptor tyrosine kinase met
|
|
TW200738638A
(en)
|
2005-06-23 |
2007-10-16 |
Merck & Co Inc |
Tyrosine kinase inhibitors
|
|
TW200740820A
(en)
|
2005-07-05 |
2007-11-01 |
Takeda Pharmaceuticals Co |
Fused heterocyclic derivatives and use thereof
|
|
US20080207572A1
(en)
|
2005-07-14 |
2008-08-28 |
Ab Science |
Use of Dual C-Kit/Fgfr3 Inhibitors for Treating Multiple Myeloma
|
|
WO2007007919A2
(en)
|
2005-07-14 |
2007-01-18 |
Astellas Pharma Inc. |
Heterocyclic janus kinase 3 inhibitors
|
|
WO2007028445A1
(en)
|
2005-07-15 |
2007-03-15 |
Glaxo Group Limited |
6-indolyl-4-yl-amino-5-halogeno-2-pyrimidinyl-amino derivatives
|
|
TW200740805A
(en)
|
2005-07-15 |
2007-11-01 |
Glaxo Group Ltd |
Novel compounds
|
|
CA2618218C
(en)
|
2005-07-21 |
2015-06-30 |
Ardea Biosciences, Inc. |
N-(arylamino)-sulfonamide inhibitors of mek
|
|
CN101198590B
(zh)
|
2005-08-24 |
2012-05-09 |
卫材R&D管理有限公司 |
吡啶衍生物及嘧啶衍生物（3）
|
|
US7884119B2
(en)
|
2005-09-07 |
2011-02-08 |
Rigel Pharmaceuticals, Inc. |
Triazole derivatives useful as Axl inhibitors
|
|
KR101415426B1
(ko)
|
2005-09-27 |
2014-07-04 |
아이알엠 엘엘씨 |
디아릴아민-함유 화합물 및 조성물, 및 ｃ-ｋｉｔ 수용체의조절제로서의 그의 용도
|
|
FR2891273B1
(fr)
|
2005-09-27 |
2007-11-23 |
Aventis Pharma Sa |
NOUVEAUX DERIVES BENZIMIDAZOLES ET BENZOTHIAZOLES, LEUR PREPARATION ET LEUR UTILISATION PHARMACEUTIQUE NOTAMMENT COMME INHIBITEURS DE CMet
|
|
SI1934174T1
(sl)
|
2005-10-07 |
2011-08-31 |
Exelixis Inc |
Inhibitorji MEK in postopki za njihovo uporabo
|
|
JP2009511528A
(ja)
|
2005-10-13 |
2009-03-19 |
グラクソ グループ リミテッド |
Ｓｙｋ阻害物質としてのピロロピリミジン誘導体群
|
|
DK1963302T3
(da)
|
2005-12-05 |
2013-04-02 |
Pfizer Prod Inc |
Polymorfer af en C-MET/HGFR-inhibitor
|
|
SG10202003901UA
(en)
|
2005-12-13 |
2020-05-28 |
Incyte Holdings Corp |
Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitors
|
|
JP2009520028A
(ja)
|
2005-12-19 |
2009-05-21 |
オーエスアイ・ファーマスーティカルズ・インコーポレーテッド |
Ｉｇｆｒ抑制剤および抗癌剤の併用
|
|
WO2007071951A1
(en)
|
2005-12-21 |
2007-06-28 |
Astrazeneca Ab |
Tosylate salt of 6- (4-br0m0-2-chl0r0phenylamin0) -7-fluoro-n- (2-hydroxyethoxy) -3-methyl-3h-benzimi dazole- 5 - carboxamide , mek inhibitor useful in the treatment of cancer
|
|
WO2007071963A2
(en)
|
2005-12-22 |
2007-06-28 |
Astrazeneca Ab |
Quinazoline derivatives, process for their preparation and their use as anti-cancer agents
|
|
UA95940C2
(uk)
|
2006-01-17 |
2011-09-26 |
Вертекс Фармасьютикалс Інкорпорейтед |
Азаіндоли як інгібітори кіназ януса
|
|
FR2896503B1
(fr)
|
2006-01-23 |
2012-07-13 |
Aventis Pharma Sa |
Nouveaux derives soufres d'uree cyclique, leur preparation et leur utilisation pharmaceutique comme inhibiteurs de kinases
|
|
FR2896504B1
(fr)
|
2006-01-23 |
2012-07-13 |
Aventis Pharma Sa |
Nouveaux derives d'uree cyclique, leur preparation et leur utilisation pharmaceutique comme inhibiteurs de kinases
|
|
WO2007085540A1
(en)
|
2006-01-27 |
2007-08-02 |
Glaxo Group Limited |
1h-indaz0l-4-yl-2 , 4-pyrimidinediamine derivatives
|
|
GB0601962D0
(en)
|
2006-01-31 |
2006-03-15 |
Ucb Sa |
Therapeutic agents
|
|
TW200740776A
(en)
|
2006-02-06 |
2007-11-01 |
Osi Pharm Inc |
N-phenylbenzotriazolyl c-kit inhibitors
|
|
JP2009533327A
(ja)
|
2006-03-22 |
2009-09-17 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
増殖性疾患を処置するためのｃ−ＭＥＴキナーゼ阻害剤
|
|
CN101415689A
(zh)
|
2006-04-05 |
2009-04-22 |
阿斯利康(瑞典)有限公司 |
具有抗癌活性的经取代的喹唑啉
|
|
JP2009532450A
(ja)
|
2006-04-05 |
2009-09-10 |
アストラゼネカ アクチボラグ |
化合物
|
|
SG170828A1
(en)
|
2006-04-05 |
2011-05-30 |
Vertex Pharmaceuticals Inc Us |
Deazapurines useful as inhibitors of janus kinases
|
|
US20090203718A1
(en)
|
2006-04-13 |
2009-08-13 |
Smithkline Beecham (Cork) Ltd. |
Cancer treatment method
|
|
JP5269762B2
(ja)
|
2006-04-18 |
2013-08-21 |
アーディア・バイオサイエンシーズ・インコーポレイテッド |
Ｍｅｋ阻害剤としてのピリドンスルホンアミドおよびピリドンスルファミド
|
|
CN101421253A
(zh)
|
2006-04-18 |
2009-04-29 |
阿斯利康(瑞典)有限公司 |
喹唑啉-4-酮衍生物、其制备方法及含有它们的药用组合物
|
|
JP5182088B2
(ja)
|
2006-04-19 |
2013-04-10 |
アステラス製薬株式会社 |
アゾールカルボキサミド誘導体
|
|
EA200802050A1
(ru)
|
2006-04-19 |
2009-04-28 |
Лаборатуар Сероно Са |
Новые гетероарилзамещенные ариламинопиридиновые производные в качестве мек ингибиторов
|
|
CA2649755C
(en)
|
2006-04-20 |
2014-12-02 |
Janssen Pharmaceutica N.V. |
Method of inhibiting c-kit kinase
|
|
JP5225264B2
(ja)
|
2006-05-09 |
2013-07-03 |
ノベアメド・リミテッド |
細胞増殖障害の処置
|
|
CN104706637A
(zh)
|
2006-05-18 |
2015-06-17 |
卫材R&D管理有限公司 |
针对甲状腺癌的抗肿瘤剂
|
|
WO2008005877A2
(en)
|
2006-06-30 |
2008-01-10 |
Board Of Regents, The University Of Texas System |
Inhibitors of c-kit and uses thereof
|
|
TW200813021A
(en)
|
2006-07-10 |
2008-03-16 |
Merck & Co Inc |
Tyrosine kinase inhibitors
|
|
AU2007275653B2
(en)
|
2006-07-20 |
2010-12-23 |
Amgen Inc. |
Benzo(d) isoxazole derivatives as c-kit tyrosine kinase inhibitors for the treatment of disorders associated with the over production of histamine
|
|
AU2007279595A1
(en)
|
2006-08-04 |
2008-02-07 |
Takeda Pharmaceutical Company Limited |
Fused heterocyclic derivative and use thereof
|
|
US20100216791A1
(en)
|
2006-08-17 |
2010-08-26 |
Astrazeneca |
Pyridinylquinazolinamine derivatives and their use as b-raf inhibitors
|
|
CN101500548A
(zh)
|
2006-08-18 |
2009-08-05 |
弗·哈夫曼-拉罗切有限公司 |
用于体内递送多核苷酸的多缀合物
|
|
CA2661333C
(en)
|
2006-08-23 |
2014-08-05 |
Eisai R&D Management Co., Ltd. |
Salt of phenoxypyridine derivative or crystal thereof and process for producing the same
|
|
CL2007002617A1
(es)
|
2006-09-11 |
2008-05-16 |
Sanofi Aventis |
Compuestos derivados de pirrolo[2,3-b]pirazin-6-ilo; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar inflamacion de las articulaciones, artritis reumatoide, tumores, linfoma de las celulas del manto.
|
|
DK2526933T3
(en)
|
2006-09-22 |
2015-05-18 |
Pharmacyclics Inc |
Inhibitors of Bruton's tyrosine kinase
|
|
WO2008045978A1
(en)
|
2006-10-10 |
2008-04-17 |
Rigel Pharmaceuticals, Inc. |
Pinane-substituted pyrimidinediamine derivatives useful as axl inhibitors
|
|
KR20090064602A
(ko)
|
2006-10-16 |
2009-06-19 |
노파르티스 아게 |
단백질 키나제 억제제로서 유용한 페닐아세트아미드
|
|
JPWO2008047831A1
(ja)
|
2006-10-17 |
2010-02-25 |
協和発酵キリン株式会社 |
Ｊａｋ阻害剤
|
|
TW200829566A
(en)
|
2006-12-08 |
2008-07-16 |
Astrazeneca Ab |
Chemical compounds
|
|
PL2101759T3
(pl)
|
2006-12-14 |
2019-05-31 |
Exelixis Inc |
Sposoby stosowania inhibitorów MEK
|
|
WO2008076143A1
(en)
|
2006-12-18 |
2008-06-26 |
Osi Pharmaceuticals, Inc. |
Combination of igfr inhibitor and anti-cancer agent
|
|
US7737149B2
(en)
|
2006-12-21 |
2010-06-15 |
Astrazeneca Ab |
N-[5-[2-(3,5-dimethoxyphenyl)ethyl]-2H-pyrazol-3-yl]-4-(3,5-dimethylpiperazin-1-yl)benzamide and salts thereof
|
|
WO2008080134A2
(en)
|
2006-12-22 |
2008-07-03 |
Rigel Pharmaceuticals, Inc. |
4-amin0-2- (hetero) arylamino-5- (hetero) arylthiazoles useful as axl inhibitors
|
|
HRP20150642T1
(hr)
|
2006-12-22 |
2015-08-14 |
Astex Therapeutics Limited |
BICIKLIÄŚKE HETEROCIKLIÄŚKE TVARI KAO INHIBITORI FGFR-a
|
|
EP2078010B1
(en)
|
2006-12-29 |
2014-01-29 |
Rigel Pharmaceuticals, Inc. |
Polycyclic heteroaryl substituted triazoles useful as axl inhibitors
|
|
WO2008083353A1
(en)
|
2006-12-29 |
2008-07-10 |
Rigel Pharmaceuticals, Inc. |
Bicyclic aryl and bicyclic heteroaryl substituted triazoles useful as axl inhibitors
|
|
US8012965B2
(en)
|
2006-12-29 |
2011-09-06 |
Rigel Pharmaceuticals, Inc. |
Bridged bicyclic aryl and bridged bicyclic heteroaryl substituted triazoles useful as axl inhibitors
|
|
CA2710046C
(en)
|
2006-12-29 |
2016-02-09 |
Rigel Pharmaceuticals, Inc. |
N3-heteroaryl substituted triazoles and n5-heteroaryl substituted triazoles useful as axl inhibitors
|
|
JP2010514810A
(ja)
|
2006-12-29 |
2010-05-06 |
ライジェル ファーマシューティカルズ， インコーポレイテッド |
Ａｘｌインヒビターとして有用な置換トリアゾール
|
|
EP1944369A1
(en)
|
2007-01-12 |
2008-07-16 |
The Centre National de la Recherche Scientifique |
Dbait and its standalone uses thereof
|
|
KR20090111847A
(ko)
|
2007-01-19 |
2009-10-27 |
아디아 바이오사이언스즈 인크. |
Ｍｅｋ 억제제
|
|
WO2008098139A2
(en)
|
2007-02-07 |
2008-08-14 |
The Regents Of The University Of Colorado |
Axl tyrosine kinase inhibitors and methods of making and using the same
|
|
AU2008217931A1
(en)
|
2007-02-23 |
2008-08-28 |
Eisai R & D Management Co., Ltd. |
Pyridine or pyrimidine derivative having excellent cell growth inhibition effect and excellent anti-tumor effect on cell strain having amplification of HGFR gene
|
|
EP2133095A4
(en)
|
2007-03-05 |
2012-09-26 |
Kyowa Hakko Kirin Co Ltd |
PHARMACEUTICAL COMPOSITION
|
|
KR101566840B1
(ko)
|
2007-03-12 |
2015-11-06 |
와이엠 바이오사이언시즈 오스트레일리아 피티와이 엘티디 |
페닐 아미노 피리미딘 화합물 및 이의 용도
|
|
MX2009010127A
(es)
|
2007-03-22 |
2009-11-05 |
Vertex Pharma |
Compuestos utiles como inhibidores de janus cinasas.
|
|
SG10202107066WA
(en)
|
2007-03-28 |
2021-07-29 |
Pharmacyclics Llc |
Inhibitors of bruton's tyrosine kinase
|
|
EP2139869A2
(en)
|
2007-04-13 |
2010-01-06 |
SuperGen, Inc. |
Axl kinase inhibitors useful for the treatment of cancer or hyperproliferative disorders
|
|
UA99459C2
(en)
|
2007-05-04 |
2012-08-27 |
Астразенека Аб |
9-(pyrazol-3-yl)- 9h-purine-2-amine and 3-(pyraz0l-3-yl)-3h-imidazo[4,5-b]pyridin-5-amine derivatives and their use for the treatment of cancer
|
|
CL2008001709A1
(es)
|
2007-06-13 |
2008-11-03 |
Incyte Corp |
Compuestos derivados de pirrolo [2,3-b]pirimidina, moduladores de quinasas jak; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como cancer, psoriasis, artritis reumatoide, entre otras.
|
|
GB0714384D0
(en)
|
2007-07-23 |
2007-09-05 |
Ucb Pharma Sa |
theraputic agents
|
|
CA2924436A1
(en)
|
2007-07-30 |
2009-02-05 |
Ardea Biosciences, Inc. |
Pharmaceutical combinations of n-(3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-6-methoxyphenyl)-1-(2,3-dihydroxypropyl)cyclopropane-1-sulfonamide as inhibitors of mek and methods of use
|
|
EA032294B1
(ru)
|
2007-07-30 |
2019-05-31 |
Арди Байосайенсиз, Инк. |
Способ получения полиморфной формы производного n-(ариламино)сульфонамида, фармацевтическая композиция, содержащая указанное производное, и способ лечения с помощью указанного производного
|
|
PA8792501A1
(es)
|
2007-08-09 |
2009-04-23 |
Sanofi Aventis |
Nuevos derivados de 6-triazolopiridacina-sulfanil benzotiazol y bencimidazol,su procedimiento de preparación,su aplicación como medicamentos,composiciones farmacéuticas y nueva utilización principalmente como inhibidores de met.
|
|
BRPI0816278A2
(pt)
|
2007-09-05 |
2015-09-22 |
Pfizer Ltd |
forma sal
|
|
CN101835755B
(zh)
|
2007-10-23 |
2013-12-11 |
霍夫曼-拉罗奇有限公司 |
激酶抑制剂
|
|
EP2206707B1
(en)
|
2007-10-24 |
2014-07-23 |
Astellas Pharma Inc. |
Azolecarboxamide compound or salt thereof
|
|
EP2205592B1
(en)
|
2007-10-26 |
2013-05-08 |
Rigel Pharmaceuticals, Inc. |
Polycyclic aryl substituted triazoles and polycyclic heteroaryl substituted triazoles useful as axl inhibitors
|
|
EP2215094B1
(en)
|
2007-11-15 |
2016-01-27 |
YM BioSciences Australia Pty Ltd |
N-containing heterocyclic compounds
|
|
US20110039856A1
(en)
|
2007-11-29 |
2011-02-17 |
Pfizer Inc. |
Polymorphs of a c-met/hgfr inhibitor
|
|
EP2240494B1
(en)
|
2008-01-21 |
2016-03-30 |
UCB Biopharma SPRL |
Thieno-pyridine derivatives as mek inhibitors
|
|
GB0801416D0
(en)
|
2008-01-25 |
2008-03-05 |
Piramed Ltd |
Pharmaceutical compounds
|
|
MX2010007973A
(es)
|
2008-02-01 |
2010-11-09 |
Akinion Pharmaceuticals Ab |
Derivados de pirazina y su uso como inhibidores de proteina cinasa.
|
|
PL2242749T3
(pl)
|
2008-02-05 |
2013-09-30 |
Hoffmann La Roche |
Nowe pirydynony i pirydazynony
|
|
EA018551B1
(ru)
|
2008-02-22 |
2013-08-30 |
Айрм Ллк |
ГЕТЕРОЦИКЛИЧЕСКИЕ СОЕДИНЕНИЯ И СОДЕРЖАЩИЕ ИХ КОМПОЗИЦИИ В КАЧЕСТВЕ ИНГИБИТОРОВ КИНАЗ c-KIT И PDGFR
|
|
CA2716947A1
(en)
|
2008-02-29 |
2009-09-11 |
Array Biopharma Inc. |
Imidazo [4,5-b] pyridine derivatives used as raf inhibitors
|
|
KR20100122505A
(ko)
|
2008-02-29 |
2010-11-22 |
어레이 바이오파마 인크. |
Ｒａｆ 저해물질 화합물 및 이들의 이용 방법
|
|
JP2011513331A
(ja)
|
2008-02-29 |
2011-04-28 |
アレイ バイオファーマ、インコーポレイテッド |
ピラゾール［３，４−ｂ］ピリジンＲＡＦ阻害剤
|
|
JP2011513332A
(ja)
|
2008-02-29 |
2011-04-28 |
アレイ バイオファーマ、インコーポレイテッド |
癌の治療のためのｒａｆ阻害剤としてのｎ−（６−アミノピリジン−３−イル）−３−（スルホンアミド）ベンズアミド誘導体
|
|
HUE029767T2
(en)
|
2008-03-11 |
2017-04-28 |
Incyte Holdings Corp |
JAK inhibitor azetidine and cyclobutane derivatives
|
|
MX2010010272A
(es)
|
2008-03-19 |
2011-05-25 |
Chembridge Corp |
Nuevos inhibidores de tirosina quinasa.
|
|
CA2721183C
(en)
|
2008-04-11 |
2019-07-16 |
Alnylam Pharmaceuticals, Inc. |
Site-specific delivery of nucleic acids by combining targeting ligands with endosomolytic components
|
|
MX2010011314A
(es)
|
2008-04-14 |
2010-11-12 |
Ardea Biosciences Inc |
Composiciones y metodos de preparacion y uso de las mismas.
|
|
HRP20161310T1
(hr)
|
2008-04-16 |
2016-12-02 |
Portola Pharmaceuticals, Inc. |
2,6-diamino-pirimidin-5-il-karboksamidi kao inhibitori syk ili jak kinaza
|
|
SG165655A1
(en)
|
2008-04-16 |
2010-11-29 |
Portola Pharm Inc |
2, 6-diamino- pyrimidin- 5-yl-carboxamides as syk or JAK kinases inhibitors
|
|
RU2010146474A
(ru)
|
2008-04-16 |
2012-05-27 |
Макс-Планк-Гезелльшафт Цур Фердерунг Дер Виссеншафтен Е.Ф. (De) |
Производные хинолина в качестве ингибиторов axl киназ
|
|
AU2009238590A1
(en)
|
2008-04-22 |
2009-10-29 |
Portola Pharmaceuticals, Inc. |
Inhibitors of protein kinases
|
|
EP2274288A2
(en)
|
2008-04-24 |
2011-01-19 |
Incyte Corporation |
Macrocyclic compounds and their use as kinase inhibitors
|
|
MX353308B
(es)
|
2008-05-21 |
2018-01-08 |
Ariad Pharma Inc |
Derivados fosforosos como inhibidores de cinasa.
|
|
TWI472529B
(zh)
|
2008-05-21 |
2015-02-11 |
Incyte Corp |
２－氟－Ｎ－甲基－４－〔７－（喹啉－６－基－甲基）－咪唑并〔１，２－ｂ〕〔１，２，４〕三－２－基〕苯甲醯胺之鹽類及其相關製備方法
|
|
GB0811304D0
(en)
|
2008-06-19 |
2008-07-30 |
Ucb Pharma Sa |
Therapeutic agents
|
|
CA2728063A1
(en)
|
2008-06-19 |
2009-12-23 |
Astrazeneca Ab |
Pyrazole compounds 436
|
|
CN102131389A
(zh)
|
2008-06-20 |
2011-07-20 |
健泰科生物技术公司 |
三唑并吡啶jak抑制剂化合物和方法
|
|
WO2009155565A1
(en)
|
2008-06-20 |
2009-12-23 |
Genentech, Inc. |
Triazolopyridine jak inhibitor compounds and methods
|
|
PH12012502374A1
(en)
|
2008-06-24 |
2014-11-12 |
Hoffmann La Roche |
Novel substituted pyridin-2-ones and pyridazin-3-ones
|
|
JP5613156B2
(ja)
|
2008-07-09 |
2014-10-22 |
ライジェル ファーマシューティカルズ， インコーポレイテッド |
Ａｘｌ阻害剤として有用な架橋二環ヘテロアリール置換トリアゾール
|
|
ES2537480T3
(es)
|
2008-07-09 |
2015-06-08 |
Rigel Pharmaceuticals, Inc. |
Triazoles sustituidos con heteroarilo policíclicos útiles como inhibidores de Axl
|
|
CA2730930C
(en)
|
2008-07-16 |
2015-01-13 |
Pharmacyclics, Inc. |
Inhibitors of bruton's tyrosine kinase for the treatment of solid tumors
|
|
CN102159559A
(zh)
|
2008-07-18 |
2011-08-17 |
赛诺菲-安万特 |
新型咪唑并[1,2-a]吡啶衍生物、其制备方法、其作为药物的用途、其药物组合物和新型用途特别是作为MET抑制剂的新型用途
|
|
FR2933982A1
(fr)
|
2008-07-18 |
2010-01-22 |
Sanofi Aventis |
Nouveaux derives imidazo°1,2-a!pyrimidine, leur procede de preparation, leur application a titre de medicaments, compositions pharmaceutiques et nouvelle utilisation notamment comme inhibiteurs de met
|
|
JP2011528337A
(ja)
|
2008-07-18 |
2011-11-17 |
サノフイ−アベンテイス |
新規トリアゾロ［４，３−ａ］ピリジン誘導体、これらの調製方法、医薬としてのこれらの使用、医薬組成物および、特にｍｅｔ阻害剤としての、新規使用
|
|
HRP20160044T1
(hr)
|
2008-08-04 |
2016-02-26 |
Merck Patent Gmbh |
Novi spojevi fenilamino izonikotinamida
|
|
UY32049A
(es)
|
2008-08-14 |
2010-03-26 |
Takeda Pharmaceutical |
Inhibidores de cmet
|
|
WO2010033941A1
(en)
|
2008-09-22 |
2010-03-25 |
Array Biopharma Inc. |
Substituted imidazo[1,2b]pyridazine compounds as trk kinase inhibitors
|
|
MY169791A
(en)
|
2008-10-22 |
2019-05-15 |
Array Biopharma Inc |
Substituted pyrazolo [1,5-a] pyrimidine compounds as trk kinase inhibitors
|
|
EP2348860B1
(en)
|
2008-10-31 |
2015-05-27 |
Genentech, Inc. |
Pyrazolopyrimidine jak inhibitor compounds and methods
|
|
US8598174B2
(en)
|
2008-11-12 |
2013-12-03 |
Genetech, Inc. |
Pyridazinones, method of making, and method of use thereof
|
|
JP5596047B2
(ja)
|
2008-11-19 |
2014-09-24 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
ｃ−Ｍｅｔタンパク質キナーゼのトリアゾロチアジアゾール阻害剤
|
|
PE20120121A1
(es)
|
2008-12-08 |
2012-02-20 |
Gilead Connecticut Inc |
Derivados de imidazopirazina como inhibidores de syk
|
|
PL2716157T3
(pl)
|
2008-12-08 |
2017-06-30 |
Gilead Connecticut, Inc. |
Imidazopirazynowe inhibitory Syk
|
|
ITMI20082336A1
(it)
|
2008-12-29 |
2010-06-30 |
Univ Parma |
Composti inibitori irreversibili di egfr con attivita' antiproliferativa
|
|
US8470835B2
(en)
|
2009-01-13 |
2013-06-25 |
Glaxo Group Limited |
Pyrimidinecarboxamide derivatives as inhibitors of Syk kinase
|
|
TWI720517B
(zh)
|
2009-01-15 |
2021-03-01 |
美商英塞特公司 |
製造ｊａｋ抑制劑之方法及相關中間化合物
|
|
PL2387395T3
(pl)
|
2009-01-16 |
2015-03-31 |
Rigel Pharmaceuticals Inc |
Inhibitory Axl do zastosowania w terapii skojarzonej do zapobiegania, leczenia lub postępowania z nowotworem przerzutowym
|
|
WO2010085597A1
(en)
|
2009-01-23 |
2010-07-29 |
Incyte Corporation |
Macrocyclic compounds and their use as kinase inhibitors
|
|
FR2941952B1
(fr)
|
2009-02-06 |
2011-04-01 |
Sanofi Aventis |
Derives de 6-(6-substitue-triazolopyridazine-sulfanyl) 5-fluoro-benzothiazoles et 5-fluoro-benzimidazoles : preparation, application comme medicaments et utilisation comme inhibiteurs de met.
|
|
FR2941951B1
(fr)
|
2009-02-06 |
2011-04-01 |
Sanofi Aventis |
Derives de 6-(6-nh-substitue-triazolopyridazine-sulfanyl) benzothiazoles et benzimidazoles : preparation, application comme medicaments et utilisation comme inhibiteurs de met.
|
|
TW201041892A
(en)
|
2009-02-09 |
2010-12-01 |
Supergen Inc |
Pyrrolopyrimidinyl Axl kinase inhibitors
|
|
CN102448938A
(zh)
|
2009-03-27 |
2012-05-09 |
阿迪生物科学公司 |
作为mek抑制剂的二氢吡啶磺酰胺和二氢吡啶硫酰胺
|
|
CA2761108A1
(en)
|
2009-04-21 |
2010-10-28 |
Novartis Ag |
Heterocyclic compounds as mek inhibitors
|
|
US8765754B2
(en)
|
2009-04-29 |
2014-07-01 |
Locus Pharmaceuticals, Inc. |
Pyrrolotriazine compounds
|
|
US9908884B2
(en)
|
2009-05-05 |
2018-03-06 |
Dana-Farber Cancer Institute, Inc. |
EGFR inhibitors and methods of treating disorders
|
|
SI2432472T1
(sl)
|
2009-05-22 |
2019-11-29 |
Incyte Holdings Corp |
3-(4-(7H-pirolo(2,3-d)pirimidin-4-il)-1H-pirazol-1-il)oktan- ali heptan-nitril kot inhibitorji JAK
|
|
ES2575084T3
(es)
|
2009-06-10 |
2016-06-24 |
Chugai Seiyaku Kabushiki Kaisha |
Compuesto tetracíclico
|
|
TW201103904A
(en)
|
2009-06-11 |
2011-02-01 |
Hoffmann La Roche |
Janus kinase inhibitor compounds and methods
|
|
WO2010147898A2
(en)
|
2009-06-15 |
2010-12-23 |
Rigel Pharmaceuticals, Inc. |
Small molecule inhibitors of spleen tyrosine kinase (syk)
|
|
CN102134218A
(zh)
|
2009-06-15 |
2011-07-27 |
凯美隆(北京)药业技术有限公司 |
6-芳氨基吡啶酮磺酰胺和6-芳氨基吡嗪酮磺酰胺mek抑制剂
|
|
TWI462920B
(zh)
|
2009-06-26 |
2014-12-01 |
葛萊伯格有限公司 |
用於治療退化性及發炎疾病之新穎化合物
|
|
UA110324C2
(en)
|
2009-07-02 |
2015-12-25 |
Genentech Inc |
Jak inhibitory compounds based on pyrazolo pyrimidine
|
|
AR077468A1
(es)
|
2009-07-09 |
2011-08-31 |
Array Biopharma Inc |
Compuestos de pirazolo (1,5 -a) pirimidina sustituidos como inhibidores de trk- quinasa
|
|
US8722692B2
(en)
|
2009-07-30 |
2014-05-13 |
Jianwei Che |
Compounds and compositions as Syk kinase inhibitors
|
|
TW201105669A
(en)
|
2009-07-30 |
2011-02-16 |
Irm Llc |
Compounds and compositions as Syk kinase inhibitors
|
|
US20130018033A1
(en)
|
2009-08-28 |
2013-01-17 |
Array Biopharma Inc. |
Raf inhibitor compounds and methods of use thereof
|
|
JP2013503190A
(ja)
|
2009-08-28 |
2013-01-31 |
アレイ バイオファーマ、インコーポレイテッド |
Ｒａｆ阻害化合物およびその使用方法
|
|
WO2011025965A1
(en)
|
2009-08-28 |
2011-03-03 |
Genentech, Inc. |
Raf inhibitor compounds and methods of use thereof
|
|
WO2011025968A1
(en)
|
2009-08-28 |
2011-03-03 |
Array Biopharma Inc. |
1h-pyrazolo [ 3, 4-b] pyridine compounds for inhibiting raf kinase
|
|
NZ598985A
(en)
|
2009-09-04 |
2013-07-26 |
Biogen Idec Inc |
Bruton's tyrosine kinase inhibitors
|
|
EP2485589A4
(en)
|
2009-09-04 |
2013-02-06 |
Biogen Idec Inc |
HETEROARYL-BTK INHIBITORS
|
|
JP5775085B2
(ja)
|
2009-09-30 |
2015-09-09 |
メルク シャープ エンド ドーム リミテッド |
ｃ−ＭＥＴキナーゼ阻害剤の製剤
|
|
CN102666512B
(zh)
|
2009-10-13 |
2014-11-26 |
奥斯特姆医疗公司 |
对疾病治疗有用的mek抑制剂
|
|
HUE067723T2
(hu)
|
2009-10-16 |
2024-11-28 |
Novartis Ag |
MEK-inhibitort és B-Raf-inhibitort tartalmazó kombináció
|
|
AU2010317167B2
(en)
|
2009-11-04 |
2012-11-29 |
Novartis Ag |
Heterocyclic sulfonamide derivatives useful as MEK inhibitors
|
|
KR101445012B1
(ko)
|
2009-12-17 |
2014-09-26 |
머크 샤프 앤드 돔 코포레이션 |
Ｓｙｋ 억제제로서의 아미노피리미딘
|
|
EP2512246B1
(en)
|
2009-12-17 |
2015-09-30 |
Merck Sharp & Dohme Corp. |
Aminopyrimidines as syk inhibitors
|
|
MY156701A
(en)
|
2009-12-23 |
2016-03-15 |
Arqule Inc |
Purified pyrroloquinolinyl-pyrrolidine-2,5-dione compositions and methods for preparing and using same
|
|
NZ601267A
(en)
|
2009-12-23 |
2014-03-28 |
Takeda Pharmaceutical |
Fused heteroaromatic pyrrolidinones as syk inhibitors
|
|
EP2338888A1
(en)
|
2009-12-24 |
2011-06-29 |
Almirall, S.A. |
Imidazopyridine derivatives as JAK inhibitors
|
|
WO2011090738A2
(en)
|
2009-12-29 |
2011-07-28 |
Dana-Farber Cancer Institute, Inc. |
Type ii raf kinase inhibitors
|
|
ES2539170T3
(es)
|
2010-01-12 |
2015-06-26 |
Ab Science |
Inhibidores de quinasas de oxazol
|
|
PH12012501535A1
(en)
|
2010-01-29 |
2012-10-22 |
Boehringer Ingelheim Int |
Substituted naphthyridines and their use as syk kinase inhibitors
|
|
AU2011226689B2
(en)
|
2010-03-11 |
2016-09-01 |
Kronos Bio, Inc. |
Imidazopyridines Syk inhibitors
|
|
US8481541B2
(en)
|
2010-03-22 |
2013-07-09 |
Hoffmann-La Roche Inc. |
Pyrrolopyrazine kinase inhibitors
|
|
US8957216B2
(en)
|
2010-03-24 |
2015-02-17 |
Amitech Therapeutic Solutions, Inc. |
Heterocyclic compounds useful for kinase inhibition
|
|
TW201202242A
(en)
|
2010-03-30 |
2012-01-16 |
Sanofi Aventis |
6-(alkyl-or cycloalkyl-triazolopyridazine-sulfanyl)benzo-thiazole derivatives: preparation, and use as medicaments and as MET inhibitors
|
|
GB201007203D0
(en)
|
2010-04-29 |
2010-06-16 |
Glaxo Group Ltd |
Novel compounds
|
|
US8916593B2
(en)
|
2010-05-04 |
2014-12-23 |
Pfizer Inc. |
Alkoxy-substituted 2-aminopyridines as ALK inhibitors
|
|
EP2569315A1
(en)
|
2010-05-14 |
2013-03-20 |
OSI Pharmaceuticals, LLC |
Fused bicyclic kinase inhibitors
|
|
MX2012013378A
(es)
|
2010-05-20 |
2013-01-24 |
Hoffmann La Roche |
Derivados de pirrolo [2, 3-b] pirazina-7-carboxamida y sus uso como inhibidores de cinasa janus (jak) y cinasa tirosina del brazo (syk).
|
|
EP2571881A1
(en)
|
2010-05-20 |
2013-03-27 |
F.Hoffmann-La Roche Ag |
Pyrrolopyrazine derivatives as syk and jak inhibitors
|
|
JP2013527195A
(ja)
|
2010-05-27 |
2013-06-27 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
ｃ−Ｍｅｔプロテインキナーゼのアミノピラゾールトリアゾロチアジアゾールインヒビター
|
|
US8669256B2
(en)
|
2010-05-28 |
2014-03-11 |
Merck Sharp & Dohme B.V. |
Substituted thieno[2,3-b]pyrazine compounds as modulators of B-Raf kinase activity
|
|
TWI500617B
(zh)
|
2010-05-31 |
2015-09-21 |
Ono Pharmaceutical Co |
Purine ketone derivatives
|
|
CA3007787C
(en)
|
2010-06-03 |
2020-03-10 |
Pharmacyclics Llc |
The use of inhibitors of bruton's tyrosine kinase (btk)
|
|
JP5860874B2
(ja)
|
2010-06-22 |
2016-02-16 |
デエヌア・テラプーティックＤｎａｔｈｅｒａｐｅｕｔｉｃｓ |
核酸コンジュゲートのためのエンドソーム溶解剤を用いた最適化ｉｎｖｉｖｏ送達システム
|
|
ES2689103T3
(es)
|
2010-06-30 |
2018-11-08 |
Fujifilm Corporation |
Nuevo derivado de nicotinamida o sal del mismo
|
|
WO2012005299A1
(ja)
|
2010-07-07 |
2012-01-12 |
日本新薬株式会社 |
Ｒｏｓチロシンキナーゼ阻害剤
|
|
ES2598530T3
(es)
|
2010-07-14 |
2017-01-27 |
Betta Pharmaceuticals Co., Ltd. |
Nuevos derivados heterocíclicos condensados útiles como inhibidores de la tirosina quinasa c-Met
|
|
US20130225581A1
(en)
|
2010-07-16 |
2013-08-29 |
Kyowa Hakko Kirin Co., Ltd |
Nitrogen-containing aromatic heterocyclic derivative
|
|
WO2012008564A1
(ja)
|
2010-07-16 |
2012-01-19 |
協和発酵キリン株式会社 |
含窒素芳香族複素環誘導体
|
|
AR085183A1
(es)
|
2010-07-30 |
2013-09-18 |
Lilly Co Eli |
Compuesto 6-(1-metil-1h-pirazol-4-il)-3-(2-metil-2h-indazol-5-iltio)-[1,2,4]triazol[4,3-b]piridazina, composicion farmaceutica que lo comprende y uso para preparar un medicamento util para tratar cancer
|
|
UY33539A
(es)
|
2010-08-02 |
2012-02-29 |
Astrazeneca Ab |
Compuestos químicos alk
|
|
MX336875B
(es)
|
2010-08-10 |
2016-02-04 |
Celgene Avilomics Res Inc |
Sal de besilato de un inhibidor de tirosina cinasa de bruton (btk).
|
|
CN103052386B
(zh)
|
2010-08-20 |
2016-03-02 |
中外制药株式会社 |
含有四环化合物的组合物
|
|
EA201300283A1
(ru)
|
2010-08-27 |
2013-08-30 |
Мерк Патент Гмбх |
Производные фуропиридина
|
|
EA201300282A1
(ru)
|
2010-08-27 |
2013-08-30 |
Мерк Патент Гмбх |
Производные триазолопиразина
|
|
EP2423208A1
(en)
|
2010-08-28 |
2012-02-29 |
Lead Discovery Center GmbH |
Pharmaceutically active compounds as Axl inhibitors
|
|
UY33597A
(es)
|
2010-09-09 |
2012-04-30 |
Irm Llc |
Compuestos y composiciones como inhibidores de la trk
|
|
US8664244B2
(en)
|
2010-09-12 |
2014-03-04 |
Advenchen Pharmaceuticals, LLC |
Compounds as c-Met kinase inhibitors
|
|
WO2012037155A2
(en)
|
2010-09-13 |
2012-03-22 |
Gtx, Inc. |
Tyrosine kinase inhibitors
|
|
JO3062B1
(ar)
|
2010-10-05 |
2017-03-15 |
Lilly Co Eli |
R)-(e)-2-(4-(2-(5-(1-(3، 5-داي كلورو بيريدين-4-يل)إيثوكسي)-1h-إندازول-3-يل)?ينيل)-1h-بيرازول-1-يل)إيثانول بلوري
|
|
CA2813580C
(en)
|
2010-10-08 |
2017-12-05 |
Xcovery Holding Company, Llc |
Substituted pyridazine carboxamide compounds as kinase inhibitor compounds
|
|
CA2816219C
(en)
|
2010-11-01 |
2019-10-29 |
Portola Pharmaceuticals, Inc. |
Nicotinamides as syk modulators
|
|
CN102020651B
(zh)
|
2010-11-02 |
2012-07-18 |
北京赛林泰医药技术有限公司 |
6-芳基氨基吡啶酮甲酰胺mek抑制剂
|
|
CN102532141A
(zh)
|
2010-12-08 |
2012-07-04 |
中国科学院上海药物研究所 |
[1，2，4]三唑并[4，3-b][1，2，4]三嗪类化合物、其制备方法和用途
|
|
US20130004481A1
(en)
|
2011-01-12 |
2013-01-03 |
Boehringer Ingelheim International Gmbh |
Anticancer therapy
|
|
MA34969B1
(fr)
|
2011-02-25 |
2014-03-01 |
Irm Llc |
Composes et compositions en tant qu inibiteurs de trk
|
|
EP2683716A1
(en)
|
2011-03-11 |
2014-01-15 |
Glaxo Group Limited |
Pyrido[3,4-b]pyrazine derivatives as syk inhibitors
|
|
GB201104153D0
(en)
|
2011-03-11 |
2011-04-27 |
Glaxo Group Ltd |
Novel compounds
|
|
EP2691399B1
(en)
|
2011-03-28 |
2016-07-13 |
F.Hoffmann-La Roche Ag |
Thiazolopyrimidine compounds
|
|
ES2759615T3
(es)
|
2011-04-01 |
2020-05-11 |
Univ Utah Res Found |
Análogos de N-fenilpirimidina-2-amina sustituidos como inhibidores de la quinasa AXL
|
|
JP6147727B2
(ja)
|
2011-04-01 |
2017-06-14 |
ユニヴァーシティー オブ ユタ リサーチ ファウンデーション |
チロシン受容体キナーゼｂｔｋ阻害剤としての置換ｎ−（３−（ピリミジン−４−イル）フェニル）アクリルアミド類似体
|
|
PH12013502020A1
(en)
|
2011-04-05 |
2018-04-11 |
Pfizer Ltd |
Pyrrolo [2,3-d] pyrimidine derivatives as inhibitors of tropomyosin-related kinases
|
|
JP5934782B2
(ja)
|
2011-05-04 |
2016-06-15 |
メルク・シャープ・アンド・ドーム・コーポレーションＭｅｒｃｋ Ｓｈａｒｐ ＆ Ｄｏｈｍｅ Ｃｏｒｐ． |
アミノ−ピリジン含有脾臓チロシンキナーゼ（Ｓｙｋ）阻害薬
|
|
US9145391B2
(en)
|
2011-05-10 |
2015-09-29 |
Merck Sharp & Dohme Corp. |
Bipyridylaminopyridines as Syk inhibitors
|
|
CA2834062A1
(en)
|
2011-05-10 |
2012-11-15 |
Merck Sharp & Dohme Corp. |
Pyridyl aminopyridines as syk inhibitors
|
|
EP2706853B1
(en)
|
2011-05-10 |
2017-06-14 |
Merck Sharp & Dohme Corp. |
Aminopyrimidines as syk inhibitors
|
|
CA2835835C
(en)
|
2011-05-13 |
2019-04-02 |
Array Biopharma Inc. |
Pyrrolidinyl urea and pyrrolidinyl thiourea compounds as trka kinase inhibitors
|
|
EP2527440A1
(en)
*
|
2011-05-27 |
2012-11-28 |
Institut Curie |
Cancer treatment by combining DNA molecules mimicking double strand breaks with hyperthermia
|
|
WO2012167423A1
(en)
|
2011-06-08 |
2012-12-13 |
Hutchison Medipharma Limited |
Substituted pyridopyrazines as novel syk inhibitors
|
|
CN102816162B
(zh)
|
2011-06-10 |
2016-04-27 |
中国科学院广州生物医药与健康研究院 |
嘧啶并嘧啶酮类化合物及其药用组合物和应用
|
|
MX354412B
(es)
|
2011-06-10 |
2018-03-05 |
Merck Patent Gmbh |
Composiciones y metodos para la produccion de compuestos de pirimidina con actividad inhibidora de tirosina cinasa de bruton.
|
|
CN102393896B
(zh)
|
2011-07-11 |
2014-08-27 |
成都西谷曙光数字技术有限公司 |
一种简单精确的射频定位系统和方法
|
|
EP2731439A4
(en)
|
2011-07-12 |
2014-12-03 |
Merck Sharp & Dohme |
TRKA KINASE INHIBITORS, COMPOSITIONS AND METHOD THEREFOR
|
|
EP3689878B1
(en)
|
2011-07-19 |
2021-10-06 |
Merck Sharp & Dohme B.V. |
4-imidazopyridazin-1-yl-benzamides and 4-imidazotriazin-1-yl-benzamides as btk-inhibitors
|
|
CA2841887A1
(en)
|
2011-07-19 |
2013-01-24 |
Merck Sharp & Dohme B.V. |
4-imidazopyridazin-1-yl-benzamides and 4-imidazotriazin-1-yl-benzamides as btk - inhibitors
|
|
EP2548877A1
(en)
|
2011-07-19 |
2013-01-23 |
MSD Oss B.V. |
4-(5-Membered fused pyridinyl)benzamides as BTK-inhibitors
|
|
CN103732588B
(zh)
|
2011-07-27 |
2016-10-12 |
南京奥昭生物科技有限公司 |
螺环分子作为蛋白激酶抑制剂
|
|
CN103717591B
(zh)
|
2011-07-27 |
2016-08-24 |
Ab科学有限公司 |
作为选择性蛋白激酶(c-kit)抑制剂的噁唑和噻唑衍生物
|
|
JP2014525450A
(ja)
|
2011-09-01 |
2014-09-29 |
アイアールエム・リミテッド・ライアビリティ・カンパニー |
ｃ−Ｋｉｔキナーゼ阻害剤としての化合物および組成物
|
|
EP2751104B1
(en)
|
2011-09-01 |
2019-09-25 |
Novartis AG |
Compounds and compositions as c-kit kinase inhibitors
|
|
EA201490537A1
(ru)
|
2011-09-01 |
2014-07-30 |
АйАрЭм ЭлЭлСи |
СОЕДИНЕНИЯ И КОМПОЗИЦИИ В КАЧЕСТВЕ ИНГИБИТОРОВ КИНАЗЫ C-Kit
|
|
US9199981B2
(en)
|
2011-09-01 |
2015-12-01 |
Novartis Ag |
Compounds and compositions as C-kit kinase inhibitors
|
|
CN115403531A
(zh)
|
2011-09-14 |
2022-11-29 |
润新生物公司 |
作为激酶抑制剂的化学实体、组合物及方法
|
|
WO2013047813A1
(ja)
|
2011-09-30 |
2013-04-04 |
大鵬薬品工業株式会社 |
１，２，４－トリアジン－６－カルボキサミド誘導体
|
|
US9216173B2
(en)
|
2011-10-05 |
2015-12-22 |
Merck Sharp & Dohme Corp. |
2-Pyridyl carboxamide-containing spleen tyrosine kinase (SYK) inhibitors
|
|
WO2013052391A1
(en)
|
2011-10-05 |
2013-04-11 |
Merck Sharp & Dohme Corp. |
PHENYL CARBOXAMIDE-CONTAINING SPLEEN TYROSINE KINASE (Syk) INHIBITORS
|
|
EP2763975B1
(en)
|
2011-10-05 |
2016-04-06 |
Merck Sharp & Dohme Corp. |
3-pyridyl carboxamide-containing spleen tyrosine kinase (syk) inhibitors
|
|
UA111382C2
(uk)
|
2011-10-10 |
2016-04-25 |
Оріон Корпорейшн |
Інгібітори протеїнкінази
|
|
MX391121B
(es)
|
2011-10-19 |
2025-03-19 |
Pharmacyclics Llc |
Uso de inhibidores de la tirosina cinasa de bruton (btk).
|
|
KR20140095513A
(ko)
|
2011-11-01 |
2014-08-01 |
에프. 호프만-라 로슈 아게 |
이미다조피리다진 화합물
|
|
MX2014005282A
(es)
|
2011-11-03 |
2014-05-30 |
Hoffmann La Roche |
Compuestos de 8-fluoroftalazin-1 (2h) -ona.
|
|
EP2773639B1
(en)
|
2011-11-03 |
2017-04-26 |
F. Hoffmann-La Roche AG |
Alkylated piperazine compounds as inhibitors of btk activity
|
|
UA111756C2
(uk)
|
2011-11-03 |
2016-06-10 |
Ф. Хоффманн-Ля Рош Аг |
Сполуки гетероарилпіридону та азапіридону як інгібітори тирозинкінази брутона
|
|
SG11201402004YA
(en)
|
2011-11-14 |
2014-05-29 |
Cephalon Inc |
Uracil derivatives as axl and c-met kinase inhibitors
|
|
US9199997B2
(en)
|
2011-11-29 |
2015-12-01 |
Ono Pharmaceutical Co., Ltd. |
Purinone derivative hydrochloride
|
|
AU2012351748B2
(en)
|
2011-12-12 |
2016-04-14 |
Dr. Reddy's Laboratories Ltd. |
Substituted pyrazolo[1,5-a] pyridine as tropomyosin receptor kinase (Trk) inhibitors
|
|
PT2796460T
(pt)
|
2011-12-21 |
2018-11-05 |
Shanghai hengrui pharmaceutical co ltd |
Derivado pirrole de anel heteroarilo de seis membros, método de preparação do mesmo e suas utilizações médicas
|
|
EP2799431B1
(en)
|
2011-12-28 |
2018-01-24 |
FUJIFILM Corporation |
Novel nicotinamide derivative or salt thereof
|
|
US8377946B1
(en)
|
2011-12-30 |
2013-02-19 |
Pharmacyclics, Inc. |
Pyrazolo[3,4-d]pyrimidine and pyrrolo[2,3-d]pyrimidine compounds as kinase inhibitors
|
|
EP2802590B1
(en)
|
2012-01-10 |
2017-03-01 |
F. Hoffmann-La Roche AG |
Thienopyrimidine compounds
|
|
CN104159891B
(zh)
|
2012-01-10 |
2016-09-07 |
霍夫曼-拉罗奇有限公司 |
哒嗪酰胺化合物和它们作为syk 抑制剂的用途
|
|
CN103204844A
(zh)
|
2012-01-17 |
2013-07-17 |
上海艾力斯医药科技有限公司 |
氨基杂芳基化合物及其制备方法与应用
|
|
CN103204825B
(zh)
|
2012-01-17 |
2015-03-04 |
上海科州药物研发有限公司 |
作为蛋白激酶抑制剂的苯并噻唑化合物及其制备方法和用途
|
|
MY171055A
(en)
|
2012-01-19 |
2019-09-23 |
Taiho Pharmaceutical Co Ltd |
3,5-disubstituted alkynylbenzene compound and salt thereof
|
|
US8871778B2
(en)
|
2012-01-20 |
2014-10-28 |
Genosco |
Substituted pyrimidine compounds and their use as SYK inhibitors
|
|
US8501724B1
(en)
|
2012-01-31 |
2013-08-06 |
Pharmacyclics, Inc. |
Purinone compounds as kinase inhibitors
|
|
DK2810937T3
(en)
|
2012-01-31 |
2017-03-13 |
Daiichi Sankyo Co Ltd |
PYRIDONE DERIVATIVES
|
|
CA2863717C
(en)
|
2012-02-21 |
2021-09-28 |
Lars Burgdorf |
Furopyridine derivatives
|
|
CN104114557B
(zh)
|
2012-02-21 |
2017-10-24 |
默克专利股份公司 |
作为syk酪氨酸激酶抑制剂和gcn2丝氨酸激酶抑制剂的8‑取代2‑氨基‑[1,2,4]三唑并[1,5‑a]吡嗪
|
|
US9073944B2
(en)
|
2012-02-21 |
2015-07-07 |
Merck Patent Gmbh |
Cyclic diaminopyrimidine derivatives
|
|
WO2013124869A2
(en)
|
2012-02-21 |
2013-08-29 |
Amrita Vishwa Vidyapeetham University |
The art, method,manner process and system of fibrous bio-degradable polymeric wafers for the local delivery of therapeutic agents in combinations
|
|
KR102032007B1
(ko)
|
2012-02-28 |
2019-10-14 |
아스텔라스세이야쿠 가부시키가이샤 |
질소 함유 방향족 헤테로환 화합물
|
|
NZ629432A
(en)
|
2012-03-14 |
2017-01-27 |
Lupin Ltd |
Heterocyclyl compounds as mek inhibitors
|
|
CA2866852C
(en)
|
2012-03-15 |
2020-12-29 |
Celgene Avilomics Research, Inc. |
Solid forms of an epidermal growth factor receptor kinase inhibitor
|
|
US8877763B2
(en)
|
2012-03-22 |
2014-11-04 |
Genosco |
Substituted pyridopyrimidine compounds and their use as FLT3 inhibitors
|
|
US9365566B2
(en)
|
2012-03-27 |
2016-06-14 |
Takeda Pharmaceutical Company Limited |
Cinnoline derivatives
|
|
US20150072019A1
(en)
|
2012-03-30 |
2015-03-12 |
Novartis Ag |
Fgfr inhibitor for use in the treatment of hypophosphatemic disorders
|
|
AU2013243097A1
(en)
|
2012-04-03 |
2014-10-09 |
Novartis Ag |
Combination products with tyrosine kinase inhibitors and their use
|
|
CN104203242B
(zh)
|
2012-04-04 |
2017-03-15 |
杭州德润玉成生物科技有限公司 |
取代的喹啉类作为布鲁顿酪氨酸激酶抑制剂
|
|
HRP20180037T1
(hr)
|
2012-04-17 |
2018-03-23 |
Fujifilm Corporation |
Heterociklični spoj koji sadrži dušik ili njegovu sol
|
|
PL2838998T3
(pl)
|
2012-04-18 |
2018-04-30 |
Cell Signaling Technology, Inc. |
EGFR i ROS1 w nowotworze
|
|
TW201350479A
(zh)
|
2012-04-26 |
2013-12-16 |
Ono Pharmaceutical Co |
Ｔｒｋ阻害化合物
|
|
US9670213B2
(en)
|
2012-05-14 |
2017-06-06 |
East China University Of Science And Technology |
Pteridine ketone derivative and applications thereof as EGFR, BLK, and FLT3 inhibitor
|
|
WO2013176970A1
(en)
|
2012-05-22 |
2013-11-28 |
Merck Sharp & Dohme Corp. |
TrkA KINASE INHIBITORS, COMPOSITIONS AND METHODS THEREOF
|
|
GB201209613D0
(en)
|
2012-05-30 |
2012-07-11 |
Astex Therapeutics Ltd |
New compounds
|
|
CN104470918A
(zh)
|
2012-05-30 |
2015-03-25 |
日本新药株式会社 |
芳香族杂环衍生物及医药
|
|
TWI585088B
(zh)
|
2012-06-04 |
2017-06-01 |
第一三共股份有限公司 |
作爲激酶抑制劑之咪唑并［１，２－ｂ］嗒衍生物
|
|
AR091273A1
(es)
|
2012-06-08 |
2015-01-21 |
Biogen Idec Inc |
Inhibidores de pirimidinil tirosina quinasa
|
|
RS58514B1
(sr)
|
2012-06-13 |
2019-04-30 |
Incyte Holdings Corp |
Supstituisana triciklična jedinjenja kao inhibitori fgfr
|
|
AU2013274641B2
(en)
|
2012-06-14 |
2015-09-24 |
Eli Lilly And Company |
Inhibitor of JAK1 and JAK2
|
|
EP2863913B1
(en)
|
2012-06-20 |
2018-09-12 |
Merck Sharp & Dohme Corp. |
Imidazolyl analogs as syk inhibitors
|
|
EP2863914B1
(en)
|
2012-06-20 |
2018-10-03 |
Merck Sharp & Dohme Corp. |
Pyrazolyl derivatives as syk inhibitors
|
|
EP2863915B1
(en)
|
2012-06-22 |
2017-12-06 |
Merck Sharp & Dohme Corp. |
SUBSTITUTED DIAZINE AND TRIAZINE SPLEEN TYROSINE KINASE (Syk) INHIBITORS
|
|
EP2863916B1
(en)
|
2012-06-22 |
2018-07-18 |
Merck Sharp & Dohme Corp. |
Substituted pyridine spleen tyrosine kinase (syk) inhibitors
|
|
TWI520962B
(zh)
|
2012-06-29 |
2016-02-11 |
|
As the c-Met tyrosine kinase inhibitors novel fused pyridine derivatives
|
|
CA2782774A1
(en)
|
2012-07-06 |
2014-01-06 |
Pharmascience Inc. |
Protein kinase inhibitors
|
|
WO2014009319A1
(en)
|
2012-07-11 |
2014-01-16 |
Boehringer Ingelheim International Gmbh |
Indolinone derivatives anticancer compounds
|
|
JP6374384B2
(ja)
|
2012-08-07 |
2018-08-15 |
メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングＭｅｒｃｋ Ｐａｔｅｎｔ Ｇｅｓｅｌｌｓｃｈａｆｔ ｍｉｔ ｂｅｓｃｈｒａｅｎｋｔｅｒ Ｈａｆｔｕｎｇ |
プロテインキナーゼ阻害剤としてのピリドピリミジン誘導体
|
|
US9388185B2
(en)
|
2012-08-10 |
2016-07-12 |
Incyte Holdings Corporation |
Substituted pyrrolo[2,3-b]pyrazines as FGFR inhibitors
|
|
SG11201500499TA
(en)
|
2012-08-10 |
2015-03-30 |
Boehringer Ingelheim Int |
Heteroaromatic compounds as bruton's tyrosine kinase (btk) inhibitors
|
|
CN104520297B
(zh)
|
2012-08-13 |
2016-08-24 |
瑞士诺华动物保健有限公司 |
作为肾酪氨酸激酶抑制剂的双环杂芳基环烷基二胺衍生物
|
|
US9353066B2
(en)
|
2012-08-20 |
2016-05-31 |
Merck Sharp & Dohme Corp. |
Substituted phenyl-Spleen Tyrosine Kinase (Syk) inhibitors
|
|
KR20150043323A
(ko)
|
2012-08-21 |
2015-04-22 |
에프. 호프만-라 로슈 아게 |
비장 티로신 키나제 억제제로서 피롤로[2,3-b]피라진
|
|
CN103122000B
(zh)
|
2012-09-03 |
2013-12-25 |
中美冠科生物技术（太仓）有限公司 |
用作抗肿瘤药物的高选择性的c-Met激酶抑制剂
|
|
SI2892900T1
(en)
|
2012-09-10 |
2018-01-31 |
Principia Biopharma Inc. |
Pyrazolopyrimidine compounds as kinase inhibitors
|
|
WO2014045029A1
(en)
|
2012-09-18 |
2014-03-27 |
Ziarco Pharma Ltd |
2-(2-aminocyclohexyl)amino-pyrimidine-5-carboxamides as spleen tyrosine kinasei(syk) inhibitors
|
|
MY170904A
(en)
|
2012-09-25 |
2019-09-13 |
Chugai Pharmaceutical Co Ltd |
Ret inhibitor
|
|
WO2014051654A2
(en)
|
2012-09-27 |
2014-04-03 |
Portola Pharmaceuticals, Inc. |
Bicyclic oxa-lactam kinase inhibitors
|
|
WO2014048065A1
(en)
|
2012-09-28 |
2014-04-03 |
Merck Sharp & Dohme Corp. |
Triazolyl derivatives as syk inhibitors
|
|
WO2014055928A2
(en)
|
2012-10-04 |
2014-04-10 |
University Of Utah Research Foundation |
Substituted n-(3-(pyrimidin-4-yl)phenyl)acrylamide analogs as tyrosine receptor kinase btk inhibitors
|
|
CA2887465A1
(en)
|
2012-10-04 |
2014-04-10 |
University Of Utah Research Foundation |
Substituted n-(3-(pyrimidin-4-yl)phenyl)acrylamide analogs as tyrosine receptor kinase btk inhibitors
|
|
WO2014060371A1
(en)
|
2012-10-19 |
2014-04-24 |
F. Hoffmann-La Roche Ag |
Inhibitors of syk
|
|
CA2880326A1
(en)
|
2012-10-26 |
2014-05-01 |
F. Hoffmann-La Roche Ag |
3,4-disubstituted 1 h-pyrazole and 4,5-disubstituted thiazole inhibitors of syk cap
|
|
KR101668574B1
(ko)
|
2012-11-02 |
2016-10-24 |
화이자 인코포레이티드 |
브루톤 티로신 키나제 억제제
|
|
CN102977014B
(zh)
|
2012-11-05 |
2015-01-07 |
沈阳药科大学 |
新的喹啉类化合物及其用途
|
|
WO2014074422A1
(en)
|
2012-11-07 |
2014-05-15 |
Merck Sharp & Dohme Corp. |
Amino-pyridine-containing spleen tyrosine kinase (syk) inhibitors
|
|
WO2014078417A1
(en)
|
2012-11-13 |
2014-05-22 |
Array Biopharma Inc. |
Pyrazolyl urea, thiourea, guanidine and cyanoguanidine compounds as trka kinase inhibitors
|
|
WO2014078372A1
(en)
|
2012-11-13 |
2014-05-22 |
Array Biopharma Inc. |
Pyrrolidinyl urea, thiourea, guanidine and cyanoguanidine compounds as trka kinase inhibitors
|
|
WO2014078328A1
(en)
|
2012-11-13 |
2014-05-22 |
Array Biopharma Inc. |
N-bicyclic aryl,n'-pyrazolyl urea, thiourea, guanidine and cyanoguanidine compounds as trka kinase inhibitors
|
|
MX374242B
(es)
|
2012-11-13 |
2025-03-05 |
Array Biopharma Inc |
Compuestos de n-pirrolidinil, n' -pirazolil-urea, tiourea, guanidina y cianoguanidina como inhibidores de trka cinasa.
|
|
WO2014078378A1
(en)
|
2012-11-13 |
2014-05-22 |
Array Biopharma Inc. |
Pyrrolidinyl urea, thiourea, guanidine and cyanoguanidine compounds as trka kinase inhibitors
|
|
US9822118B2
(en)
|
2012-11-13 |
2017-11-21 |
Array Biopharma Inc. |
Bicyclic heteroaryl urea, thiourea, guanidine and cyanoguanidine compounds as TrkA kinase inhibitors
|
|
WO2014078325A1
(en)
|
2012-11-13 |
2014-05-22 |
Array Biopharma Inc. |
N-(monocyclic aryl),n'-pyrazolyl-urea, thiourea, guanidine and cyanoguanidine compounds as trka kinase inhibitors
|
|
US9981959B2
(en)
|
2012-11-13 |
2018-05-29 |
Array Biopharma Inc. |
Thiazolyl and oxazolyl urea, thiourea, guanidine and cyanoguanidine compounds as TrkA kinase inhibitors
|
|
WO2014078331A1
(en)
|
2012-11-13 |
2014-05-22 |
Array Biopharma Inc. |
N-(arylalkyl)-n'-pyrazolyl-urea, thiourea, guanidine and cyanoguanidine compounds as trka kinase inhibitors
|
|
EA201590855A1
(ru)
|
2012-11-15 |
2015-11-30 |
Фармасайкликс, Инк. |
Соединения пирролопиримидина как ингибиторы киназ
|
|
CN103848810A
(zh)
|
2012-11-30 |
2014-06-11 |
北京赛林泰医药技术有限公司 |
鲁顿酪氨酸激酶抑制剂
|
|
US20150307491A1
(en)
|
2012-12-07 |
2015-10-29 |
Hutchison Medipharma Limited |
Substituted pyridopyrazines as syk inhibitors
|
|
EP2931281B1
(en)
|
2012-12-12 |
2018-01-17 |
Merck Sharp & Dohme Corp. |
Amino-pyrimidine-containing spleen tyrosine kinase inhibitors
|
|
EP2934525B1
(en)
|
2012-12-21 |
2019-05-08 |
Merck Sharp & Dohme Corp. |
Thiazole-substituted aminopyridines as spleen tyrosine kinase inhibitors
|
|
US9499519B2
(en)
|
2012-12-26 |
2016-11-22 |
Medivation Technologies, Inc. |
Fused pyrimidine compounds and use thereof
|
|
DK2940014T3
(en)
|
2012-12-28 |
2018-12-10 |
Crystalgenomics Inc |
2,3-DIHYDRO-ISOINDOL-1-ON DERIVATIVE AS BTK KINase INHIBITORS AND PHARMACEUTICAL COMPOSITION INCLUDING THE SAME
|
|
WO2014111037A1
(zh)
|
2013-01-18 |
2014-07-24 |
上海昀怡健康管理咨询有限公司 |
五元并六元杂环化合物、其制备方法、药物组合物和应用
|
|
WO2014113932A1
(en)
|
2013-01-23 |
2014-07-31 |
Merck Sharp & Dohme Corp. |
Btk inhibitors
|
|
US20140206681A1
(en)
|
2013-01-23 |
2014-07-24 |
Ronald M. Kim |
Btk inhibitors
|
|
WO2014113942A1
(en)
|
2013-01-23 |
2014-07-31 |
Merck Sharp & Dohme Corp. |
Btk inhibitors
|
|
JP6248948B2
(ja)
|
2013-02-08 |
2017-12-20 |
日産化学工業株式会社 |
３環性ピロロピリジン化合物及びｊａｋ阻害剤
|
|
AU2014219855B2
(en)
|
2013-02-19 |
2017-09-28 |
Ono Pharmaceutical Co., Ltd. |
Trk-inhibiting compound
|
|
AR094812A1
(es)
|
2013-02-20 |
2015-08-26 |
Eisai R&D Man Co Ltd |
Derivado de piridina monocíclico como inhibidor del fgfr
|
|
US9708326B2
(en)
|
2013-02-25 |
2017-07-18 |
Pharmacyclics Llc |
Inhibitors of bruton's tyrosine kinase
|
|
EA025561B1
(ru)
|
2013-03-11 |
2017-01-30 |
Игнита, Инк. |
Твёрдые формы производного хиназолина и их применение в качестве ингибитора braf
|
|
JO3377B1
(ar)
|
2013-03-11 |
2019-03-13 |
Takeda Pharmaceuticals Co |
مشتقات بيريدينيل وبيريدينيل مندمج
|
|
US9963452B2
(en)
|
2013-03-14 |
2018-05-08 |
Augusta Pharmaceuticals Inc. |
Methods, compounds, and compositions for inhibition of ROS
|
|
JP6403751B2
(ja)
|
2013-03-14 |
2018-10-10 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
５−チアゾールカルボキサミン誘導体及びｂｔｋ阻害剤としてのその使用
|
|
JP6495886B2
(ja)
|
2013-03-15 |
2019-04-03 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
Ｂｔｋ阻害剤としての複素環式芳香族化合物
|
|
WO2014146492A1
(en)
|
2013-03-19 |
2014-09-25 |
Merck Sharp & Dohme Corp. |
N-(2-cyano heterocyclyl)pyrazolo pyridones as janus kinase inhibitors
|
|
RU2634723C2
(ru)
|
2013-04-02 |
2017-11-03 |
Ф. Хоффманн-Ля Рош Аг |
Ингибиторы тирозинкиназы брутона
|
|
TWI628176B
(zh)
|
2013-04-04 |
2018-07-01 |
奧利安公司 |
蛋白質激酶抑制劑
|
|
US10072298B2
(en)
*
|
2013-04-17 |
2018-09-11 |
Life Technologies Corporation |
Gene fusions and gene variants associated with cancer
|
|
PH12015502383B1
(en)
|
2013-04-19 |
2023-02-03 |
Incyte Holdings Corp |
Bicyclic heterocycles as fgfr inhibitors
|
|
EP2988749B1
(en)
|
2013-04-26 |
2019-08-14 |
Merck Sharp & Dohme Corp. |
Thiazole-substituted aminopyrimidines as spleen tyrosine kinase inhibitors
|
|
WO2014176210A1
(en)
|
2013-04-26 |
2014-10-30 |
Merck Sharp & Dohme Corp. |
Thiazole-substituted aminoheteroaryls as spleen tyrosine kinase inhibitors
|
|
WO2014180182A1
(zh)
|
2013-05-10 |
2014-11-13 |
江苏豪森药业股份有限公司 |
[1,2,4]三唑并[4,3-a]吡啶类衍生物，其制备方法或其在医药上的应用
|
|
HUE033587T2
(hu)
|
2013-05-17 |
2017-12-28 |
Incyte Corp |
Bipirazol-származékok mint JAK inhibitorok
|
|
WO2014187319A1
(en)
|
2013-05-21 |
2014-11-27 |
Jiangsu Medolution Ltd |
Substituted pyrazolopyrimidines as kinases inhibitors
|
|
CA2912806A1
(en)
|
2013-05-29 |
2014-12-04 |
Cephalon, Inc. |
Pyrrolotriazines as alk inhibitors
|
|
WO2014204263A1
(en)
|
2013-06-20 |
2014-12-24 |
The Asan Foundation |
Substituted pyridinone compounds as mek inhibitors
|
|
TW201534597A
(zh)
|
2013-06-20 |
2015-09-16 |
Ab Science |
作為選擇性蛋白質激酶抑制劑之苯并咪唑衍生物
|
|
WO2014210255A1
(en)
|
2013-06-26 |
2014-12-31 |
Abbvie Inc. |
Primary carboxamides as btk inhibitors
|
|
EA029412B1
(ru)
|
2013-06-28 |
2018-03-30 |
Бейджин, Лтд. |
Конденсированные трициклические соединения мочевины в качестве ингибиторов киназы raf и/или димера киназы raf
|
|
WO2015002894A1
(en)
|
2013-07-02 |
2015-01-08 |
Pharmacyclics, Inc. |
Purinone compounds as kinase inhibitors
|
|
TWI649308B
(zh)
|
2013-07-24 |
2019-02-01 |
小野藥品工業股份有限公司 |
喹啉衍生物
|
|
EP3628749A1
(en)
|
2013-07-30 |
2020-04-01 |
Blueprint Medicines Corporation |
Ntrk2 fusions
|
|
RS58361B1
(sr)
|
2013-07-31 |
2019-03-29 |
Merck Patent Gmbh |
Piridini, pirimidini i pirazini, kao inhibitori btk i njihova upotreba
|
|
SG11201600373YA
(en)
|
2013-07-31 |
2016-02-26 |
Gilead Sciences Inc |
Syk inhibitors
|
|
EP3027623A4
(en)
|
2013-08-02 |
2017-03-01 |
Ignyta, Inc. |
METHODS OF TREATING VARIOUS CANCERS USING AN AXL/cMET INHIBITOR ALONE OR IN COMBINATION WITH OTHER AGENTS
|
|
MX360498B
(es)
|
2013-08-12 |
2018-11-05 |
Taiho Pharmaceutical Co Ltd |
Compuesto novedoso de pirimidina fusionada o sal del mismo.
|
|
US9227969B2
(en)
|
2013-08-14 |
2016-01-05 |
Novartis Ag |
Compounds and compositions as inhibitors of MEK
|
|
WO2015031666A1
(en)
|
2013-08-28 |
2015-03-05 |
Irm Llc |
Combination of an alk inhibitor and a cdk inhibitor for the treatment of cell proliferative diseases
|
|
KR101879422B1
(ko)
|
2013-09-18 |
2018-07-17 |
베이징 한미 파마슈티컬 컴퍼니 리미티드 |
Btk 및/또는 jak3 키나제의 활성을 억제하는 화합물
|
|
WO2015039333A1
(en)
|
2013-09-22 |
2015-03-26 |
Merck Sharp & Dohme Corp. |
TrkA KINASE INHIBITORS, COMPOSITIONS AND METHODS THEREOF
|
|
WO2015039334A1
(en)
|
2013-09-22 |
2015-03-26 |
Merck Sharp & Dohme Corp. |
TrkA KINASE INHIBITORS, COMPOSITIONS AND METHODS THEREOF
|
|
KR102272792B1
(ko)
|
2013-09-30 |
2021-07-05 |
광저우 이노케어 파마 테크 씨오., 엘티디. |
Ｂｔｋ의 치환된 니코틴이미드 저해제 및 그의 제조 방법 및 암, 염증 및 자가면역 질환에의 용도
|
|
BR112016006978A2
(pt)
|
2013-09-30 |
2017-08-01 |
Pharmacyclics Llc |
inibidores de tirosina quinase de bruton
|
|
KR101744033B1
(ko)
|
2013-10-16 |
2017-06-07 |
후지필름 가부시키가이샤 |
함질소 복소환 화합물의 염 또는 그 결정, 의약 조성물 및 flt3 저해제
|
|
PL3060562T3
(pl)
|
2013-10-21 |
2022-01-10 |
Genosco |
Podstawione związki pirymidynowe i ich zastosowanie jako inhibitory syk
|
|
BR112016008632A8
(pt)
|
2013-10-21 |
2020-03-17 |
Merck Patent Gmbh |
compostos de heteroarila como inibidores de btk, seus usos, e composição farmacêutica
|
|
JP6403172B2
(ja)
|
2013-10-25 |
2018-10-10 |
シャンハイ ヘンルイ ファーマスーティカル カンパニー リミテッドＳｈａｎｇｈａｉ Ｈｅｎｇｒｕｉ Ｐｈａｒｍａｃｅｕｔｉｃａｌ Ｃｏ．， Ｌｔｄ． |
ピリジンのケトン誘導体、それらの製造方法、およびそれらの医薬適用
|
|
TN2016000115A1
(en)
|
2013-10-25 |
2017-07-05 |
Novartis Ag |
Ring-fused bicyclic pyridyl derivatives as fgfr4 inhibitors.
|
|
JP6493218B2
(ja)
|
2013-11-08 |
2019-04-03 |
小野薬品工業株式会社 |
ピロロピリミジン誘導体
|
|
EP3078659B1
(en)
|
2013-12-02 |
2017-11-15 |
Jenkem Technology Co., Ltd. (Beijing) |
3-furyl-2-cyano-2-acrylamide derivative, preparation method therefor, pharmaceutical composition and use thereof
|
|
US9382246B2
(en)
|
2013-12-05 |
2016-07-05 |
Pharmacyclics Llc |
Inhibitors of Bruton's tyrosine kinase
|
|
TWI731317B
(zh)
|
2013-12-10 |
2021-06-21 |
美商健臻公司 |
原肌球蛋白相關之激酶（ｔｒｋ）抑制劑
|
|
WO2015095444A1
(en)
|
2013-12-20 |
2015-06-25 |
Merck Sharp & Dohme Corp. |
Thiazole-substituted aminoheteroaryls as spleen tyrosine kinase inhibitors
|
|
US9822107B2
(en)
|
2013-12-20 |
2017-11-21 |
Merck Sharp & Dohme Corp. |
Thiazole-substituted aminoheteroaryls as spleen tyrosine kinase inhibitors
|
|
US9834554B2
(en)
|
2013-12-20 |
2017-12-05 |
Merck Sharp & Dohme Corp. |
BTK inhibitors
|
|
WO2015095099A1
(en)
|
2013-12-20 |
2015-06-25 |
Merck Sharp & Dohme Corp. |
Btk inhibitors
|
|
WO2015094997A1
(en)
|
2013-12-20 |
2015-06-25 |
Merck Sharp & Dohme Corp. |
Thiazole-substituted aminoheteroaryls as spleen tyrosine kinase inhibitors
|
|
TWI735853B
(zh)
|
2013-12-23 |
2021-08-11 |
美商克洛諾斯生技有限公司 |
脾酪胺酸激酶抑制劑
|
|
AU2014370186A1
(en)
|
2013-12-26 |
2016-07-14 |
Ignyta, Inc. |
Pyrazolo[1,5-a]pyridine derivatives and methods of their use
|
|
JP6486954B2
(ja)
|
2014-01-29 |
2019-03-20 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
Ｂｔｋ阻害剤としてのピラゾール化合物
|
|
WO2015132799A2
(en)
|
2014-02-03 |
2015-09-11 |
Cadila Healthcare Limited |
Novel heterocyclic compounds
|
|
US11045468B2
(en)
|
2014-02-04 |
2021-06-29 |
Astellas Pharma Inc. |
Pharmaceutical composition comprising diamino heterocyclic carboxamide compound as active ingredient
|
|
AU2014384476B2
(en)
|
2014-02-27 |
2017-12-21 |
Ascentage Pharma (Suzhou) Co., Ltd. |
Indoloquinolone compounds as anaplastic lymphoma kinase (ALK) inhibitors
|
|
WO2015138273A1
(en)
|
2014-03-13 |
2015-09-17 |
Merck Sharp & Dohme Corp. |
2-pyrazine carboxamides as spleen tyrosine kinase inhibitors
|
|
AU2015233654B2
(en)
|
2014-03-19 |
2018-12-06 |
Boehringer Ingelheim International Gmbh |
Heteroaryl Syk inhibitors
|
|
US10053455B2
(en)
|
2014-03-24 |
2018-08-21 |
Ab Science |
Diazaspiroalkaneone-substituted oxazole derivatives as spleen tyrosine kinase inhibitors
|
|
WO2015143652A1
(en)
|
2014-03-26 |
2015-10-01 |
Merck Sharp & Dohme Corp. |
TrkA KINASE INHIBITORS,COMPOSITIONS AND METHODS THEREOF
|
|
WO2015143654A1
(en)
|
2014-03-26 |
2015-10-01 |
Merck Sharp & Dohme Corp. |
TrkA KINASE INHIBITORS,COMPOSITIONS AND METHODS THEREOF
|
|
WO2015143653A1
(en)
|
2014-03-26 |
2015-10-01 |
Merck Sharp & Dohme Corp. |
TrkA KINASE INHIBITORS,COMPOSITIONS AND METHODS THEREOF
|
|
ES2715676T3
(es)
|
2014-03-27 |
2019-06-05 |
Janssen Pharmaceutica Nv |
Derivados de 4,5,6,7-tetrahidro-pirazolo[1,5-a]pirazina sustituidos y derivados de 5,6,7,8-tetrahidro-4h-pirazolo[1,5-a][1,4]diazepina como inhibidores de ros1
|
|
US10342795B2
(en)
|
2014-03-27 |
2019-07-09 |
Janssen Pharmaceutica Nv |
Substituted 4,5,6,7-tetrahydro-pyrazolo[1,5-a]pyrimidine derivatives and 2,3-dihydro-1H-imidazo[1,2-b]pyrazole derivatives as ROS1 inhibitors
|
|
US20170137426A1
(en)
|
2014-03-28 |
2017-05-18 |
Changzhou Jiekai Pharmatech Co., Ltd. |
Heterocyclic compounds as axl inhibitors
|
|
CN105017256A
(zh)
|
2014-04-29 |
2015-11-04 |
浙江导明医药科技有限公司 |
多氟化合物作为布鲁顿酪氨酸激酶抑制剂
|
|
CN105085474B
(zh)
|
2014-05-07 |
2018-05-18 |
北京赛林泰医药技术有限公司 |
鲁顿酪氨酸激酶抑制剂
|
|
BR112016023299A8
(pt)
|
2014-05-14 |
2021-06-29 |
Nissan Chemical Ind Ltd |
composto tricíclico e inibidor de jak, agente preventivo, terapêutico ou de melhoria para doenças contra as quais inibição de jak é eficaz e para artrite reumatoide, medicamento e utilização desses compostos
|
|
MA40434B1
(fr)
|
2014-05-15 |
2019-09-30 |
Array Biopharma Inc |
1-((3s,4r)-4-(3-fluorophényl)-1-(2-méthoxyéthyl)pyrrolidin-3-yl)-3-(4-méthyl-3-(2-méthylpyrimidin-5-yl)-1-phényl-1h-pyrazol-5-yl)urée comme inhibiteur de la kinase trka
|
|
AU2015266453C1
(en)
|
2014-05-30 |
2018-09-13 |
Shanghai Emerald Wellcares Pharmaceutical Co., Ltd |
Alk kinase inhibitor, and preparation method and use thereof
|
|
EP3159338A4
(en)
|
2014-06-17 |
2018-01-24 |
Korea Research Institute of Chemical Technology |
Pyrimidine-2,4-diamine derivative and anticancer pharmaceutical composition comprising same as effective ingredient
|
|
WO2015200341A1
(en)
|
2014-06-23 |
2015-12-30 |
Dr. Reddy's Laboratories Ltd. |
Substituted imidazo[1,2-a]pyridine compounds useful for the treatment of pain
|
|
TWI723572B
(zh)
|
2014-07-07 |
2021-04-01 |
日商第一三共股份有限公司 |
具有四氫吡喃基甲基之吡啶酮衍生物及其用途
|
|
TW201617074A
(zh)
|
2014-07-14 |
2016-05-16 |
吉李德科學股份有限公司 |
Ｓｙｋ（脾酪胺酸激酶）抑制劑
|
|
AU2015296215A1
(en)
|
2014-08-01 |
2017-03-23 |
Pharmacyclics Llc |
Inhibitors of bruton's tyrosine kinase
|
|
WO2016021629A1
(ja)
|
2014-08-06 |
2016-02-11 |
塩野義製薬株式会社 |
ＴｒｋＡ阻害活性を有する複素環および炭素環誘導体
|
|
NO2721710T3
(https=)
|
2014-08-21 |
2018-03-31 |
|
|
|
KR101710127B1
(ko)
|
2014-08-29 |
2017-02-27 |
한화제약주식회사 |
야누스인산화효소 억제제로서의 치환된 N-(피롤리딘-3-일)-7H-피롤로[2,3-d]피리미딘-4-아민
|
|
US20170281641A1
(en)
|
2014-09-03 |
2017-10-05 |
Genzyme Corporation |
CYCLIC UREA COMPOUNDS AS TROPOMYOSIN-RELATED KINASE (TRK) iNHIBITORS
|
|
CN105524068B
(zh)
|
2014-09-30 |
2017-11-24 |
上海海雁医药科技有限公司 |
氮杂双环衍生物、其制法与医药上的用途
|
|
JP6585167B2
(ja)
|
2014-10-03 |
2019-10-02 |
ノバルティス アーゲー |
Ｆｇｆｒ４阻害剤としての縮環二環式ピリジル誘導体の使用
|
|
US10253023B2
(en)
|
2014-10-06 |
2019-04-09 |
Merck Patent Gmbh |
Heteroaryl compounds as BTK inhibitors and uses thereof
|
|
WO2016054987A1
(zh)
|
2014-10-11 |
2016-04-14 |
上海翰森生物医药科技有限公司 |
Egfr抑制剂及其制备和应用
|
|
MX2017005060A
(es)
|
2014-10-24 |
2017-07-05 |
Bristol Myers Squibb Co |
Compuestos atropisomeros triciclicos.
|
|
CN107148421A
(zh)
|
2014-10-30 |
2017-09-08 |
桑多斯股份公司 |
活性丙烯酰胺类化合物
|
|
CN105085489B
(zh)
|
2014-11-05 |
2019-03-01 |
益方生物科技（上海）有限公司 |
嘧啶或吡啶类化合物、其制备方法和医药用途
|
|
US9862712B2
(en)
|
2014-11-20 |
2018-01-09 |
Council Of Scientific & Industrial Research |
Benzimidazole based EGFR inhibitors
|
|
CN105601573B
(zh)
|
2014-11-24 |
2021-07-02 |
中国科学院上海药物研究所 |
2-氨基嘧啶类化合物及其药物组合物和应用
|
|
KR20170090431A
(ko)
|
2014-12-11 |
2017-08-07 |
바이엘 파마 악티엔게젤샤프트 |
범 ｆｇｆｒ 억제제의 용도 및 범 ｆｇｆｒ 억제제를 사용하는 치료에 대하여 적격인 암 환자를 확인하는 방법
|
|
JP6621477B2
(ja)
|
2014-12-18 |
2019-12-18 |
ファイザー・インク |
ピリミジンおよびトリアジン誘導体ならびにａｘｌ阻害薬としてのそれらの使用
|
|
ES2749726T3
(es)
|
2014-12-25 |
2020-03-23 |
Ono Pharmaceutical Co |
Derivado de quinolina
|
|
WO2016106626A1
(en)
|
2014-12-31 |
2016-07-07 |
Merck Sharp & Dohme Corp. |
Imidazopyrazine analogs with 3-tertiary carbon substitutions as btk inhibitors
|
|
WO2016106629A1
(en)
|
2014-12-31 |
2016-07-07 |
Merck Sharp & Dohme Corp. |
Btk inhibitors
|
|
WO2016106628A1
(en)
|
2014-12-31 |
2016-07-07 |
Merck Sharp & Dohme Corp. |
Btk inhibitors
|
|
WO2016106652A1
(en)
|
2014-12-31 |
2016-07-07 |
Merck Sharp & Dohme Corp. |
Biarylether imidazopyrazine btk inhibitors
|
|
WO2016106623A1
(en)
|
2014-12-31 |
2016-07-07 |
Merck Sharp & Dohme Corp. |
Benzamide imidazopyrazine btk inhibitors
|
|
WO2016106624A1
(en)
|
2014-12-31 |
2016-07-07 |
Merck Sharp & Dohme Corp. |
Tertiary alcohol imidazopyrazine btk inhibitors
|
|
WO2016106627A1
(en)
|
2014-12-31 |
2016-07-07 |
Merck Sharp & Dohme Corp. |
Btk inhibitors
|
|
CN104530063B
(zh)
|
2015-01-13 |
2017-01-18 |
北京赛特明强医药科技有限公司 |
喹唑啉并杂环类化合物及其制备方法和作为用于治疗癌症的表皮生长因子受体抑制剂的应用
|
|
CN105837576B
(zh)
|
2015-01-14 |
2019-03-26 |
湖北生物医药产业技术研究院有限公司 |
Btk抑制剂
|
|
EA036122B1
(ru)
|
2015-01-20 |
2020-09-30 |
Уси Форчун Фармасьютикал Ко., Лтд |
Ингибитор jak
|
|
CA2974784A1
(en)
|
2015-01-23 |
2016-07-28 |
Gvk Biosciences Private Limited |
Inhibitors of trka kinase
|
|
CA2974442A1
(en)
|
2015-02-03 |
2016-08-11 |
Trillium Therapeutics Inc. |
Novel fluorinated derivatives as egfr inhibitors useful for treating cancers
|
|
EP3253750B1
(en)
|
2015-02-03 |
2019-04-10 |
Council of Scientific and Industrial Research |
Novel flavone based egfr inhibitors and process for preparation thereof
|
|
TWI712601B
(zh)
|
2015-02-20 |
2020-12-11 |
美商英塞特公司 |
作為fgfr抑制劑之雙環雜環
|
|
WO2016161571A1
(en)
|
2015-04-08 |
2016-10-13 |
Merck Sharp & Dohme Corp. |
Indazole and azaindazole btk inhibitors
|
|
WO2016161572A1
(en)
|
2015-04-08 |
2016-10-13 |
Merck Sharp & Dohme Corp. |
TrkA KINASE INHIBITORS, COMPOSITIONS AND METHODS THEREOF
|
|
WO2016161570A1
(en)
|
2015-04-08 |
2016-10-13 |
Merck Sharp & Dohme Corp. |
Azacarbazole btk inhibitors
|
|
SG11201707638UA
(en)
|
2015-04-14 |
2017-10-30 |
Qurient Co Ltd |
Quinoline derivatives as tam rtk inhibitors
|
|
AU2016254385B2
(en)
|
2015-04-29 |
2018-05-10 |
Wuxi Fortune Pharmaceutical Co., Ltd |
JAK inhibitors
|
|
ES2753159T3
(es)
|
2015-05-28 |
2020-04-07 |
Theravance Biopharma R&D Ip Llc |
Compuestos de naftiridina como inhibidores de quinasa JAK
|
|
KR102081272B1
(ko)
|
2015-05-29 |
2020-02-25 |
우시 포춘 파마슈티컬 컴퍼니 리미티드 |
Janus 키나아제 억제제
|
|
MX2017015574A
(es)
|
2015-06-02 |
2018-08-09 |
Pharmacyclics Llc |
Inhibidores de tirosina quinasa de bruton.
|
|
UA124090C2
(uk)
|
2015-06-03 |
2021-07-21 |
Прінсіпіа Байофарма Інк. |
Інгібітори тирозинкінази
|
|
WO2016192074A1
(en)
|
2015-06-04 |
2016-12-08 |
Merck Sharp & Dohme Corp. |
Btk inhibitors
|
|
WO2016210165A1
(en)
|
2015-06-24 |
2016-12-29 |
Principia Biopharma Inc. |
Tyrosine kinase inhibitors
|
|
JP6812059B2
(ja)
|
2015-07-07 |
2021-01-13 |
塩野義製薬株式会社 |
ＴｒｋＡ阻害活性を有する複素環誘導体
|
|
CA2991020A1
(en)
|
2015-07-07 |
2017-01-12 |
Japan Tobacco Inc. |
Method for producing 7h-pyrrolo[2, 3-d]pyrimidine derivative and intermediate thereof
|
|
ES2854703T3
(es)
|
2015-07-09 |
2021-09-22 |
Merck Patent Gmbh |
Compuestos de heteroarilo como inhibidores de BTK y usos de los mismos
|
|
BR112018000808A2
(pt)
|
2015-07-16 |
2018-09-04 |
Array Biopharma Inc |
compostos de pirazolo[1,5-a]piridina substituída como inibidores de ret cinase
|
|
TWI739753B
(zh)
|
2015-07-16 |
2021-09-21 |
大陸商正大天晴藥業集團股份有限公司 |
苯胺嘧啶衍生物及其用途
|
|
WO2017015363A1
(en)
|
2015-07-20 |
2017-01-26 |
Dana-Farber Cancer Institute, Inc. |
Novel pyrimidines as egfr inhibitors and methods of treating disorders
|
|
AU2016296905B2
(en)
*
|
2015-07-23 |
2018-07-05 |
Centre National De La Recherche Scientifique |
Use of a combination of Dbait molecule and parp inhibitors to treat cancer
|
|
CN107531678B
(zh)
|
2015-07-24 |
2020-12-22 |
上海海雁医药科技有限公司 |
Egfr抑制剂及其药学上可接受的盐和多晶型物及其应用
|
|
KR101766194B1
(ko)
|
2015-08-07 |
2017-08-10 |
한국과학기술연구원 |
RET 키나아제 저해제인 신규 3-(이속사졸-3-일)-피라졸로[3,4-d]피리미딘-4-아민 화합물
|
|
CN106467541B
(zh)
|
2015-08-18 |
2019-04-05 |
暨南大学 |
取代喹诺酮类衍生物或其药学上可接受的盐或立体异构体及其药用组合物和应用
|
|
WO2017028816A1
(zh)
|
2015-08-20 |
2017-02-23 |
浙江海正药业股份有限公司 |
吲哚类衍生物及其制备方法和其在医药上的用途
|
|
MA41559A
(fr)
|
2015-09-08 |
2017-12-26 |
Taiho Pharmaceutical Co Ltd |
Composé de pyrimidine condensé ou un sel de celui-ci
|
|
JP7337502B2
(ja)
|
2015-09-16 |
2023-09-04 |
ロクソ オンコロジー， インコーポレイテッド |
がんの治療のためのｂｔｋ阻害剤としてのピラゾロピリミジン誘導体
|
|
EP3144307A1
(en)
|
2015-09-18 |
2017-03-22 |
AB Science |
Novel oxazole derivatives that inhibit syk
|
|
CN106554347B
(zh)
|
2015-09-25 |
2020-10-30 |
浙江博生医药有限公司 |
Egfr激酶抑制剂及其制备方法和应用
|
|
WO2017059280A1
(en)
|
2015-10-02 |
2017-04-06 |
The University Of North Carolina At Chapel Hill |
Novel pan-tam inhibitors and mer/axl dual inhibitors
|
|
EP3414234B1
(en)
|
2015-10-14 |
2022-06-29 |
Zibo Biopolar Changsheng Pharmaceutical Co. Ltd. |
Bruton's tyrosine kinase inhibitors
|
|
US10208024B2
(en)
|
2015-10-23 |
2019-02-19 |
Array Biopharma Inc. |
2-aryl- and 2-heteroaryl-substituted 2-pyridazin-3(2H)-one compounds as inhibitors of FGFR tyrosine kinases
|
|
UA123633C2
(uk)
|
2015-11-03 |
2021-05-05 |
Тереванс Байофарма Ар Енд Ді Айпі, Елелсі |
Сполуки інгібітору jak-кінази для лікування респіраторного захворювання
|
|
CN106699743B
(zh)
|
2015-11-05 |
2020-06-12 |
湖北生物医药产业技术研究院有限公司 |
嘧啶类衍生物及其用途
|
|
US10736893B2
(en)
|
2015-11-06 |
2020-08-11 |
Acerta Pharma B.V. |
Imidazopyrazine inhibitors of Bruton's tyrosine kinase
|
|
SG10201912607SA
(en)
|
2015-11-19 |
2020-02-27 |
Blueprint Medicines Corp |
Compounds and compositions useful for treating disorders related to ntrk
|
|
RS60237B1
(sr)
|
2015-11-24 |
2020-06-30 |
Theravance Biopharma R&D Ip Llc |
Prolekovi jak inhibitornih jedinjenja za lečenje gastorintestinalne inflamatorne bolesti
|
|
ES2830446T3
(es)
|
2015-12-11 |
2021-06-03 |
Sichuan Kelun Biotech Biopharmaceutical Co Ltd |
Derivado de azetidina, método de preparación del mismo y uso del mismo
|
|
LT3390390T
(lt)
|
2015-12-16 |
2021-11-25 |
Boehringer Ingelheim International Gmbh |
Bipirazolilo dariniai, tinkami naudoti autoimuninių ligų gydymui
|
|
CN106928231B
(zh)
|
2015-12-31 |
2021-06-01 |
合肥中科普瑞昇生物医药科技有限公司 |
一类新型的egfr野生型和突变型的激酶抑制剂
|
|
AU2017204973A1
(en)
|
2016-01-06 |
2018-07-12 |
Trillium Therapeutics Inc. |
Novel fluorinated quinazoline derivatives as EGFR inhibitors
|
|
MX382436B
(es)
|
2016-01-11 |
2025-03-13 |
Merck Patent Gmbh |
Derivados de quinolin-2-ona.
|
|
US10570118B2
(en)
|
2016-01-13 |
2020-02-25 |
Boehringer Ingelheim International Gmbh |
Isoquinolones as BTK inhibitors
|
|
KR102699906B1
(ko)
|
2016-01-21 |
2024-08-29 |
즈보 바이오폴라 창쉥 파마수티컬 컴퍼니 리미티드 |
브루톤 티로신 키나제 억제제
|
|
CN106905322B
(zh)
|
2016-01-26 |
2019-10-15 |
杭州华东医药集团新药研究院有限公司 |
吡咯嘧啶五元氮杂环衍生物及其应用
|
|
CN107021963A
(zh)
|
2016-01-29 |
2017-08-08 |
北京诺诚健华医药科技有限公司 |
吡唑稠环类衍生物、其制备方法及其在治疗癌症、炎症和免疫性疾病上的应用
|
|
WO2017135399A1
(ja)
|
2016-02-04 |
2017-08-10 |
塩野義製薬株式会社 |
ＴｒｋＡ阻害活性を有する含窒素複素環および炭素環誘導体
|
|
CA3014090A1
(en)
|
2016-02-19 |
2017-08-24 |
Jiangsu Hengrui Medicine Co., Ltd. |
Pharmaceutical composition containing jak kinase inhibitor or pharmaceutically acceptable salt thereof
|
|
CA3015484C
(en)
|
2016-02-23 |
2022-11-08 |
Taiho Pharmaceutical Co., Ltd. |
Novel condensed pyrimidine compound or salt thereof
|
|
KR102441432B1
(ko)
*
|
2016-03-01 |
2022-09-07 |
옹쎄오 |
Ｄｂａｉｔ 분자의 전신 투여에 의한 암 치료법
|
|
CN107151249B
(zh)
|
2016-03-04 |
2020-08-14 |
华东理工大学 |
作为flt3抑制剂的蝶啶酮衍生物及应用
|
|
US10183928B2
(en)
|
2016-03-17 |
2019-01-22 |
Blueprint Medicines Corporation |
Inhibitors of RET
|
|
CN107286077B
(zh)
|
2016-04-01 |
2021-04-02 |
合肥中科普瑞昇生物医药科技有限公司 |
一种选择性的c-kit激酶抑制剂
|
|
MA44789A
(fr)
|
2016-04-29 |
2019-03-06 |
X Chem Inc |
Inhibiteurs covalents de btk et leurs utilisations
|
|
MX383920B
(es)
|
2016-05-26 |
2025-03-14 |
Recurium Ip Holdings Llc |
Compuestos inhibidores de egfr.
|
|
CN107759600A
(zh)
|
2016-06-16 |
2018-03-06 |
正大天晴药业集团股份有限公司 |
作为jak抑制剂的吡咯并嘧啶化合物的结晶
|
|
US10710993B2
(en)
|
2016-06-27 |
2020-07-14 |
Hangzhou REX Pharmaceutical Co., LTD. |
Benzofuran pyrazole amine kinase inhibitor
|
|
US10640512B2
(en)
|
2016-06-30 |
2020-05-05 |
Hangzhou Sanyintai Pharmaceutical Technology Co., Ltd. |
Imidazopyrazinamine phenyl derivative and use thereof
|
|
WO2018002958A1
(en)
|
2016-06-30 |
2018-01-04 |
Sun Pharma Advanced Research Company Limited |
Novel hydrazide containing compounds as btk inhibitors
|
|
ES2965081T3
(es)
|
2016-07-07 |
2024-04-11 |
Daewoong Pharmaceutical Co Ltd |
Derivados 4-aminopirazolo[3,4-d]pirimidinil-azabiciclo y composición farmacéutica que comprende dichos derivados
|
|
CN107619388A
(zh)
|
2016-07-13 |
2018-01-23 |
南京天印健华医药科技有限公司 |
作为fgfr抑制剂的杂环化合物
|
|
US10227329B2
(en)
|
2016-07-22 |
2019-03-12 |
Blueprint Medicines Corporation |
Compounds useful for treating disorders related to RET
|
|
WO2018022761A1
(en)
|
2016-07-27 |
2018-02-01 |
Blueprint Medicines Corporation |
Substituted cyclopentane-amides for treating disorders related to ret
|
|
CN107698593A
(zh)
|
2016-08-09 |
2018-02-16 |
南京天印健华医药科技有限公司 |
作为fgfr抑制剂的杂环化合物
|
|
CN109641892B
(zh)
|
2016-08-16 |
2021-07-02 |
默克专利有限公司 |
用作可逆btk抑制剂的2-氧代-咪唑并吡啶及其用途
|
|
CN115043821B
(zh)
|
2016-08-29 |
2024-08-06 |
密歇根大学董事会 |
作为alk抑制剂的氨基嘧啶
|
|
TW201822764A
(zh)
|
2016-09-14 |
2018-07-01 |
美商基利科學股份有限公司 |
Syk抑制劑
|
|
AU2017325844A1
(en)
|
2016-09-14 |
2019-03-07 |
Gilead Sciences, Inc. |
SYK inhibitors
|
|
CN107840842A
(zh)
|
2016-09-19 |
2018-03-27 |
北京天诚医药科技有限公司 |
炔代杂环化合物、其制备方法及其在医药学上的应用
|
|
CN107840846B
(zh)
|
2016-09-19 |
2020-11-24 |
郑州泰基鸿诺医药股份有限公司 |
一种含嘧啶环的化合物、egfr抑制剂及其应用
|
|
JP2018052878A
(ja)
|
2016-09-29 |
2018-04-05 |
第一三共株式会社 |
ピリジン化合物
|
|
TWI752098B
(zh)
|
2016-10-10 |
2022-01-11 |
美商亞雷生物製藥股份有限公司 |
作為ret激酶抑制劑之經取代吡唑并[1,5-a]吡啶化合物
|
|
TWI704148B
(zh)
|
2016-10-10 |
2020-09-11 |
美商亞雷生物製藥股份有限公司 |
作為ｒｅｔ激酶抑制劑之經取代吡唑并[1,5-a]吡啶化合物
|
|
WO2018079759A1
(ja)
|
2016-10-31 |
2018-05-03 |
塩野義製薬株式会社 |
ＴｒｋＡ阻害活性を有する縮合複素環および縮合炭素環誘導体
|
|
KR102686957B1
(ko)
|
2016-11-08 |
2024-07-22 |
주식회사 대웅제약 |
신규한 피롤로피리미딘 유도체 및 이를 포함하는 약학적 조성물
|
|
WO2018090792A1
(zh)
|
2016-11-15 |
2018-05-24 |
杭州和正医药有限公司 |
一种选择性布鲁顿酪氨酸激酶抑制剂及其应用
|
|
WO2018094134A1
(en)
|
2016-11-18 |
2018-05-24 |
The Regents Of The University Of Michigan |
5,6-dihydro-11h-indolo[2,3-b]quinolin-11-ones as alk inhibitors
|
|
CN108101905A
(zh)
|
2016-11-24 |
2018-06-01 |
中国科学院上海药物研究所 |
嘧啶并[5,4-b]吲嗪或嘧啶并[5,4-b]吡呤化合物、其制备方法及用途
|
|
CN110099909B
(zh)
|
2016-12-12 |
2021-11-19 |
杭州英创医药科技有限公司 |
作为Syk抑制剂和/或Syk-HDAC双重抑制剂的杂环化合物
|
|
WO2018108064A1
(zh)
|
2016-12-13 |
2018-06-21 |
南京明德新药研发股份有限公司 |
作为第四代egfr激酶抑制剂的螺环芳基磷氧化合物
|
|
EA201991197A1
(ru)
|
2016-12-15 |
2020-01-13 |
Ариад Фармасьютикалз, Инк. |
БЕНЗИМИДАЗОЛЬНЫЕ СОЕДИНЕНИЯ В КАЧЕСТВЕ ИНГИБИТОРОВ c-Kit
|
|
CN117050032A
(zh)
|
2016-12-15 |
2023-11-14 |
阿瑞雅德制药公司 |
作为c-kit抑制剂的氨基噻唑化合物
|
|
CN108250200A
(zh)
|
2016-12-28 |
2018-07-06 |
中国科学院上海药物研究所 |
一种具有Axl抑制活性的化合物及其制备和应用
|
|
US11130761B2
(en)
|
2016-12-29 |
2021-09-28 |
Cspc Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd. |
Substituted pyrrolo[2,1-f][1,2,4]triazines as FGFR inhibitors
|
|
EP3567030B1
(en)
|
2016-12-30 |
2022-02-09 |
Medshine Discovery Inc. |
Quinazoline compound for egfr inhibition
|
|
CN108276410B
(zh)
|
2017-01-06 |
2021-12-10 |
首药控股(北京)股份有限公司 |
一种间变性淋巴瘤激酶抑制剂及其制备方法和用途
|
|
CN115737637A
(zh)
|
2017-01-10 |
2023-03-07 |
王巍 |
拉索昔芬调节膜结合雌激素信号的应用及治疗癌症的方法
|
|
WO2018136663A1
(en)
|
2017-01-18 |
2018-07-26 |
Array Biopharma, Inc. |
Ret inhibitors
|
|
WO2018136661A1
(en)
|
2017-01-18 |
2018-07-26 |
Andrews Steven W |
SUBSTITUTED PYRAZOLO[1,5-a]PYRAZINE COMPOUNDS AS RET KINASE INHIBITORS
|
|
CN106831787B
(zh)
|
2017-01-20 |
2018-10-23 |
成都倍特药业有限公司 |
用作布鲁顿酪氨酸激酶抑制剂的化合物及其制备方法和应用
|
|
US11608334B2
(en)
|
2017-02-08 |
2023-03-21 |
The National Institutes of Pharmaceutical R&D Co., Ltd. |
Pyrrolo-aromatic heterocyclic compound, preparation method therefor, and medical use thereof
|
|
US10464923B2
(en)
|
2017-02-27 |
2019-11-05 |
Merck Patent Gmbh |
Crystalline forms of 1-(4-{[6-amino-5-(4-phenoxy-phenyl)-pyrimidin-4-ylamino]-methyl}-piperidin-1-yl)-propenone
|
|
US11365196B2
(en)
|
2017-02-27 |
2022-06-21 |
Betta Pharmaceuticals Co., Ltd. |
FGFR inhibitor and application thereof
|
|
WO2018153293A1
(zh)
|
2017-02-27 |
2018-08-30 |
北京赛特明强医药科技有限公司 |
二噁烷并喹唑啉与二噁烷并喹啉类化合物及其制备方法与应用
|
|
JOP20190213A1
(ar)
|
2017-03-16 |
2019-09-16 |
Array Biopharma Inc |
مركبات حلقية ضخمة كمثبطات لكيناز ros1
|
|
WO2018175512A1
(en)
|
2017-03-22 |
2018-09-27 |
Suzhou Baijibugong Pharmaceutical Technology Co. Ltd. |
Bruton's tyrosine kinase inhibitors
|
|
WO2018187355A1
(en)
|
2017-04-03 |
2018-10-11 |
Health Research Inc. |
Met kinase inhibitors and uses therefor
|
|
CN108721298A
(zh)
|
2017-04-19 |
2018-11-02 |
华东理工大学 |
作为布鲁顿酪氨酸激酶抑制剂的嘧啶并杂环化合物及其应用
|
|
CN108727382B
(zh)
|
2017-04-19 |
2022-07-19 |
华东理工大学 |
作为btk抑制剂的杂环化合物及其应用
|
|
CN107043366B
(zh)
|
2017-04-25 |
2020-05-26 |
中国药科大学 |
4-氨基嘧啶类化合物、其制备方法及医药用途
|
|
ES2992887T3
(en)
|
2017-04-27 |
2024-12-19 |
Mochida Pharm Co Ltd |
Novel tetrahydronaphthyl urea derivatives as inhibitors of tropomyosin receptor kinase a for the treatment of pain
|
|
AR111495A1
(es)
|
2017-05-01 |
2019-07-17 |
Theravance Biopharma R&D Ip Llc |
Compuestos de imidazo-piperidina fusionada como inhibidores de jak
|
|
WO2018208132A1
(en)
|
2017-05-12 |
2018-11-15 |
Korea Research Institute Of Chemical Technology |
Pyrazolopyrimidine derivatives, preparation method thereof, and pharmaceutical composition for use in preventing or treating cancer, autoimmune disease and brain disease containing the same as an active ingredient
|
|
MX387969B
(es)
|
2017-05-22 |
2025-03-19 |
Hoffmann La Roche |
Composiciones y compuestos terapéuticos, y métodos para su uso.
|
|
CN110678467B
(zh)
|
2017-05-22 |
2023-06-13 |
豪夫迈·罗氏有限公司 |
治疗化合物和组合物及其使用方法
|
|
CN107176954B
(zh)
|
2017-06-02 |
2019-01-11 |
无锡双良生物科技有限公司 |
一种egfr抑制剂的药用盐及其晶型、制备方法和应用
|
|
AU2018286247B2
(en)
|
2017-06-14 |
2021-12-23 |
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. |
Syk inhibitor and use method therefor
|
|
CN109111446B
(zh)
|
2017-06-22 |
2021-11-30 |
上海度德医药科技有限公司 |
一种具有药物活性的杂芳基化合物
|
|
AU2018291687B2
(en)
|
2017-06-27 |
2022-07-14 |
Janssen Pharmaceutica Nv |
New quinolinone compounds
|
|
CN111093645A
(zh)
|
2017-07-05 |
2020-05-01 |
Cs制药技术有限公司 |
Egfr酪氨酸激酶的临床上重要的突变体的选择性抑制剂
|
|
US11377449B2
(en)
|
2017-08-12 |
2022-07-05 |
Beigene, Ltd. |
BTK inhibitors with improved dual selectivity
|
|
WO2019034076A1
(zh)
|
2017-08-15 |
2019-02-21 |
南京明德新药研发股份有限公司 |
Fgfr抑制剂及其医药用途
|
|
WO2019034075A1
(zh)
|
2017-08-15 |
2019-02-21 |
南京明德新药研发股份有限公司 |
Fgfr和egfr抑制剂
|
|
CN109400610A
(zh)
|
2017-08-18 |
2019-03-01 |
浙江海正药业股份有限公司 |
吡咯并三嗪类衍生物、其制备方法及其在医药上的用途
|
|
WO2019034538A1
(en)
|
2017-08-18 |
2019-02-21 |
Universität Regensburg |
SYNTHESIS, PHARMACOLOGY AND USE OF NEW FMS FLT3 TYROSINE KINASE 3 (FLT3) SELECTIVE INHIBITORS
|
|
JP2020531574A
(ja)
|
2017-08-18 |
2020-11-05 |
北京韓美薬品有限公司Ｂｅｉｊｉｎｇ Ｈａｎｍｉ Ｐｈａｒｍ． Ｃｏ．， Ｌｔｄ． |
化合物、その医薬組成物及びその使用及び応用
|